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Despite years of implementation, the program for PMTCT is not reaching the HIV positive 
pregnant women. Poor documentation as well as poor monitoring and evaluation for the program 
has contributed to the poor performance. This has led to South Africa being one of the 12 
countries in the world with an increasing child mortality rate which is related to HIV/AIDS. 
Multi-steps and the complexity of the program and poor documentation have resulted in gaps in 
the provision of care.  
Objective: The aim of the study was to assess the documentation of the core activities of 
Prevention of Mother-to-Child Transmission of HIV program provided to pregnant women from 
antenatal, maternity and post-natal care at a selected Regional hospital in Ethekwini District. 
Methods: A non-experimental retrospective descriptive exploratory design informs the study. 
Provides a description of whether the activities of PMTCT are perfomed through the use of 
documented activities on patient’s charts. A data extraction tool was used to extract information, 
with the demographic information as well as the key activities of PMTCT. One hundred and 
thirty charts of women who had delivered in the hospital of study were sampled. 
Results: The study revealed gaps in the documentation of some activities, with dual therapy 
initiated at antenatal clinic documented to be n=98(75%), whilst NVP to the baby was 105/130 
(80%). The results are in contrast with Horwood’s  (2010) study which reported  91% receiving 
the Nevirapine prophylaxis. Although there are children missed by the program, it is interesting 
to note that more babies are receiving prophylaxis compared to women receiving NVP. The cd4 
count, n=78(60%) uptake, seems not to be doing well, with only n=45(35%) , which is supported 
by Horwood’s (2010) study that showed much improvement in the cd4 uptake (70%) compared 
to the study results of 60%,  but less cd4 results documented were reported by Horwood (2010), 
showing 33% respectively. Conclusion: The National strategic Plan’s (SADOH, 2007-
2011/2013) for South Africa, as well as the global Millennium Development Goals can only be 
achieved if all the activities for the PMTCT are improved. Documentation of activities remains 
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1.1 Introduction and study background                                                                   
Human Immuno-deficiency Virus (HIV), the virus that causes Acquired Immuno-Deficiency 
Syndrome (AIDS) has become a world epidemic, and is evolving at speed around the world. 
Recently, an estimated decline in AIDS related deaths globally, from 2,1 million in 2004, to 1,8 
million in 2009 was reported (UNICEF, 2010), whereas 32,8 million people are living with HIV 
globally, compared with 33,4 million reported in 2004. The decline implies that fewer people are 
dying of AIDS related deaths.  In a global report, (2010) USAIDS estimated a 19% reduction in  
new infections of HIV/AIDS, with an estimated 5% global HIV prevalence  reported by 
UNAIDS (2010), which indicates a reduced number of people who are already infected.  
1.1.1 The situation in South African Context 
Although this seems to be positive news, South Africa remains one of the sub-Saharan African 
countries with a continued rise in maternal and child mortality, and one of the 20 countries that 
had the highest HIV burden reported worldwide (WHO, 2010) with approximately 28% 
prevalence of HIV, compared to other countries which range from 5% to 28%.  Of the 500 000 
new HIV infections in South Africa, 140 000 are from KwaZulu-Natal, which is reported to be 
the most severely affected by the epidemic (UNICEF, 2010). At the end of 2007, women 
accounted for 50% of all adults living with HIV worldwide, of which 59% are in the sub-Saharan 
region (UNAIDS, 2008). With women more greatly affected, and at higher risk compared to 
men, HIV is even more widespread in pregnant women, which results in an increased risk for 
children.  
1.1.2 The prevalence of Human Immuno-deficiency Virus in pregnant women 
The National seroprevalence Survey which reports on the infected pregnant women per annum, 
has indicated that 40, 5 % of seroprevalence is reported in South Africa as a whole, with Kwa 
Zulu-Natal second on the list amongst the provinces at 38.7% (SANDOH, 2009). The high 
prevalence has led to a rise in children dying due to HIV related causes. This prompted the need 
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for the prevention of HIV/AIDS in children.  More than 90% of children living with HIV are 
infected during pregnancy; labour, during delivery, or by breastfeeding (WHO, 2006).  
1.1.3 Reducing child mortality to curb the epidemic 
The millennium development goal for child survival requires countries to reduce child mortality 
by two thirds before 2015 (UN, 2000), which mainly are due to the burden of paediatric HIV. 
According to UNAIDS, (2010) globally an estimated 370 000 children per 1000 000 child births 
(220 000—520 000) contracted HIV during the perinatal and breastfeeding period, which has 
reduced compared to 500 000 (320 000—670 000) transmissions in previous years. This has 
been credited to the Prevention of Mother-to-Child Transmission of HIV program, as well as 
improved access to anti-retroviral treatments compared to previous years. A decline is also noted 
in the recent report from UNAIDS (2010) from 99 per 1 000 live births in 2005 as reported by 
Rollins (2006), to an estimated 61.9 deaths per 1 000 live births. The decline is not sufficient for 
South Africa to reach MDG (Millennium Development Goal 4) (2000) by 2015, which amongst 
other aims, intends to reduce child mortality by two-thirds.   
1.1.4 Interventions to reduce transmission rate 
The introduction of the Prevention of Mother-to-Child Transmission of HIV program (PMTCT) 
which aims at reducing the transmission of HIV/AIDS from HIV positive women to their 
children to improve child and maternal survival, has been a success in some countries. Botswana 
experienced reduced transmission to less than 3,5% respectively (Stringer, 2009). The results in 
Botswana, one of the countries in the sub-Saharan developing region has shown that the program 
has a high potential to improve maternal and child health, thereby reducing transmission to less 
than 5% which results in reduced child mortality, if implemented properly, and provided all the 
required interventions are documented.  
Documentation of PMTCT activities remains critical to be able to evaluate if all the processes of 
care has been rendered. As Dohrn (2008) has discovered  inconsistent documentation of cd4 cell 
count and recording of baby NVP(Nevirapine) This program can even be effective in third world 
countries, if no opportunity is missed by women and children in receiving the processes of care 
shown by documents.  Without any intervention treatment, the risk of Mother-to-Child 
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Transmission (MTCT) is estimated between 20 to 45% (WHO, 2010). This implies that if there 
is no treatment given to women and children, transmission will continue to rise, resulting in 
further child mortality.  The program requires that pregnant women attend antenatal clinics to 
access all the activities required by the program. In European countries, a transmission rate lower 
than 2% was reported after the successful implementation of the program (Doherty, 2007).  The 
rate at which sub-Saharan Africa utilises antenatal care has improved to above 90% (WHO, 
2010). This provides the opportunity of testing pregnant women so that they are able to access 
antiretroviral prophylaxis (Dual therapy) to reduce the possibility of Mother-to-Child 
Transmission. 
 
1.1.5 The importance of documentation  
The successes of the program rest on the role of the health provider in utilising the available 
interventions, as well as the quality of health service rendered. Health Systems Research (2002) 
highlighted adequate staff as the key to improving quality of care.  Documenting intervention is 
one of the crucial elements in ensuring that the quality of health service was rendered throughout 
the client’s pregnancy. 
With the revised PMTCT guideline (Dual therapy prophylaxis) which was implemented in South 
Africa from April 2002, health workers have received training that prepares them and equips 
them with the knowledge regarding the program to be able to put women on antiretroviral 
therapy, however, not all women who are eligible are reached by the program (Horwood, 2010). 
The program was revised for 2010 (DOH: 2010), but the study will focus on the DOH  
guidelines (2008). 
With the multi-step of the program, and the complexity of it occurring at different levels of care 
(antenatal clinic, maternity section, and post-natal) according to Stringer, (2009) appropriate 
documentation of the activities for the PMTCT program, effective data collection, including 
monitoring and evaluation are crucial to show performance. Documentation is an integral part of 
quality and the ensuring of safe care for patients. In nursing and health care, the patient record is 
considered a legal document, and a lawsuit can be filed against a health worker who has failed to 
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document. The continuity of care for the patient relies on what is documented (Barker, 2000), so 
that any co-worker is able to pick up a chart and understand clearly the status of the patient’s 
condition and the care rendered. With PMTCT, the requirement of the chart review remains an 
important measure to determine whether the program was implemented as planned.       
1.1.6 Core Prevention of Mother-to-Child Transmission of HIV Program activities 
In this study, these are thirteen core PMTCT activities that are undertaken during the client’s 
antenatal care through to delivery which should be documented on the patient’s records (DOH, 
2008). These activities will be regarded as the gold standard in this study for the program. 
I. Dual therapy (DT) initiated at Antenatal clinic 
A combination of two anti-retroviral prophylactics as therapy offered to HIV positive pregnant 
women to take during labour. At the time of the study this was given at 28 weeks of gestation.  
II. DT taken for more than four weeks 
Studies have proven that the longer the duration of the drug intake by pregnant women, the more 
effective it is. If the women had attended antenatal clinic regularly (at least four times or more), 
an opportunity for a longer duration of treatment would be provided by the time the women 
delivered. 
III. Dual therapy (sd NVP and AZT)  to women 
All tested HIV positive women should have received the above two drugs by the time they 
deliver. 
 
IV. AZT taken three-hourly during labour 
Guidelines stress the importance of women receiving AZT at three-hourly intervals while they 
are in labour until such time as they deliver. 
V.  Cd4 count taken 
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It is a requirement that all HIV positive women should have their cd4 cell count taken to 
determine their eligibility for lifelong Anti-retroviral (triple therapy, if cd4 is equal to or less than 
a 200 cell count) therapy. The test should be done the same day a client tests positive, to fast-
track women for treatment. 
VI. Cd4 results documented 
After the test has been carried out, the results should be available within a week or two of the 
taking of the specimen. If the results are not documented, women may miss the opportunity to be 
started on treatment in time for their own health (ART triple therapy) or for PMTCT (Dual 
therapy prophylaxis). 
VII.  Cd4 count below  
If the results are 200  or below, a woman should be prepared to start ART triple therapy (3TC, 
AZT, NVP) within two weeks.   
VIII.  above 200 cell count 
When the results come back, every woman whose cd4 count has been done should have these 
results documented in the patients’ documents.  Further management depends on whether the cd4 
count is below or above the 200 cell count. If the results are above a 200 cd4 cell count, and the 
patient was clinically assessed and found to be stage one or two (has signs that do not qualify for 
lifelong therapy) a woman should continue with dual prophylaxis.  
IX. HAART initiation if low cd4 (below 200 cd4 cell count) 
If the cd4 is 200 and below, the client should be started on  lifelong ART and not on DT within 
two weeks of testing HIV positive.   
X. The World Health Organisation clinical staging (WHO Staging). 
All women who tested HIV positive should be clinically assessed to determine eligibility for 
lifelong Antiretroviral therapy regardless of their cd4 cell count. This criterion lists all the 
clinical signs and symptoms to choose from in order to assess clients.  
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XI. Infant feeding counselling at ANC 
Women should be offered infant feeding counselling, so that they can make informed choices.  
XII. Formula feeding choice   
The formula is supplied free of charge from the public hospital, but this is only if the criteria 
called AFASS have been followed (screening assessing the accessibility, acceptability, 
feasibility, sustainability and safeness of choosing the method for feeding). This will minimise 
mixed feeding, and reduce post-natal transmission of HIV through breast milk. 
XIII. Breastfeeding. 
Choice of feeding should be made by the time of delivery. It should be clearly documented on 
the patients’ records whether breast milk or formula is the method of choice. Women make the 
choice guided by the health worker.     
XIV. NVP to baby within 72 hours 
The baby should receive NVP within 72 hours of delivery for MTCT. 
XV. DT to baby to be given at home 
Children should receive the syrup post-delivery, which mothers should continue to administer at 
home. The length of the administration of medication, whether 7 days or 4 weeks is determined 
by the length of DT by the women while pregnant. If the DT was taken for more than 4 weeks by 
the women, then the babies should be given the medication for 7 days only, but if the DT was 
taken for less than 4 weeks by the women, then the children should take a daily treatment for 4 
weeks.   
                                
1.3 Problem statement  
Documentation by health workers is critical in the provision of intervention measures. With the 
multi-steps in the provision of PMTCT activities occurring at different settings in different times, 
missed opportunities may occur at each step.   A study by Rollins (2005) revealed a gap in the 
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provision of antiretroviral prophylaxis treatment to eligible pregnant women, as well as poor 
monitoring and evaluation of the program for PMTCT. Rollins also identified that it is not drug 
availability which led to women not receiving dual prophylaxis (missed opportunities); 
according to him, the challenge was the gap in the health system, which includes monitoring 
tools, and documentation of interventions. As outlined in a recent study by Horwood (2010) 
examined the evaluation of the PMTCT and showed that gaps still exist in the provision of 
PMTCT.  
The saying goes that if it is not documented it is not done. Amongst other studies, a study in 
Nigeria, Chandra (2009) noted that the assessment of quality through reviews led to improved 
care. The study also identified poor data recording by health workers as one of the reasons 
resulting in poor scaling-up of the PMTCT.   
It is for this reason that the study will review charts to assess whether the PMTCT program 
activities are rendered as per the Department of Health guidelines (DOH, 2008).  
 
1. 4 Purpose of the study 
The aim of the study was to assess the documentation of the core activities of the Prevention of 
Mother-to-Child Transmission of HIV program provided to pregnant women in antenatal, 
maternity and post-natal care at a selected Regional hospital in the Ethekwini District. 
 
1. 5 Study Objectives 
1. To describe the processes of the PMTCT activities as documented in patients’ clinical 
records. 
2. To assess the performance of the PMTCT activities by providing the proportion of charts 
with complete documented PMTCT core activities as per revised PMTCT guidelines. 
3. To explore the relationship amongst the core activities of the PMTCT as documented in 
patients’ records.  
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1.6   Research Questions 
1. How are the processes of core PMTCT activities documented in patients’ records? 
2. What is the proportion of charts with documented core PMTCT activities in 
patients’ records?  
3. What the relationship between the core activities of PMTCT is as documented in 
the charts?  
1.7 Significance of the study 
Based on the challenges of the poor performance of the PMTCT as a result of poor 
documentation, monitoring and evaluation as documented in the background still remains vital. 
Horwood (2010) identified gaps in the provision of quality care, leading to increasing child 
mortality which still remains a challenge (Horwood, 2010). This study will provide a new body 
of knowledge as to whether core activities for the PMTCT program are provided at the 
Ethekwini District Regional hospital which will be shown by documentation. The study will add 
new knowledge in nursing practice on the value of monitoring performance through chart 
reviews, and whether the current practice has gaps which will require swift interventions. 
 The results will lead to attaining a better quality of care required to improve the health of 
people. It will show that clinical information can be used for purposes that go beyond individual 
patient care, but include chart reviews and process improvement.  
The findings as well as recommendation for this study will assist the King Edward V111 hospital 
management to emphasise importance of documentation whilst drawing up policies that will 
educate and in-service the health workforce. It will assist in increasing the accountability for 
health workers to see the need of documentation and the need for nurse managers to monitor 
closely routine charts audits and feedback on such.  This study will help the researchers to see 
the need and value of conducting the retrospective chart reviews, an action which has not been 




Key words: Prevention of Mother-to-Child Transmission of HIV (PMTCT), antenatal clinic, 
antiretroviral prophylaxis, patient-held maternity record, chart review, child mortality. 
1.8 Definition of terms:  
The keywords used will be operationalised for the study. The key concepts were adapted from 
the Department of Health (2008) Prevention of Mother-to-Child Transmission Program 
guidelines. For this study, the following concepts will be operationalised as indicated below: 
1.8.1 Mother-to-Child Transmission of HIV 
This is the transmission of HIV from the HIV positive pregnant woman to her baby. This study 
focuses more on vertical transmission than on post-natal transmission. In this study this will be 
abbreviated as MTCT, and will be used to mean the same as the DOH (2008) definition.   
1.8.2 Infant Mortality Rate 
This comprises the rate at which children die before their first birthday. 
1.8.3 Antenatal care clinic 
In this study, the Antenatal clinic is the clinic that offers antenatal services to women while they 
are pregnant. 
1.8.4 Maternity setting 
This will be operationalised to mean the setting or place where the pregnant women go into 
labour and deliver, after being pregnant. 
1.8.5 Prevalence rate 
This will be defined as the existing cases of pregnant women living with HIV. 
1.8.6 Core completeness 
This means that the information system from which the results are derived is appropriately 





1.9 THE THEORETICAL MODEL 
Donabedian Structure, Process and Outcome original model 
 
The theoretical model for this study was adapted from Donabedian’s Structure, Process, and 
Outcome. Donabedian’s (1966) structure (also called input) -  process-outcome framework 
serves as the foundation for the model of the provision of care of the program for Prevention of 
Mother-to- Child Transmission of HIV in this study.  
According to Donabedian, (1966) ‘structure’ refers to the tools and resources that participants 
have to accomplish their work. This involves the organisational setting where they work 
(Donabedian, 1988). This includes the qualifications of personnel, the geographical structure, 
and the equipment which the facilities use to provide care. It also comprises the manner in which 
the delivery of the program is organised. For Donabedian, the structure is stable, and influences 
the care that is provided.  
The process in the framework refers to a set of activities that go on within participants. This 
involves the technical and interpersonal aspect of care (Donabedian, 1966). This includes the 
social, psychological interaction between clients and participants.  
 
Outcome on the other hand, refers to the “consequences of the process on the health and welfare 
of clients” (Donabedian, 1966, p. 243).  To Donabedian, the outcome means the change in the 
client’s current and future health status. Physical, social and psychological functions comprise 
the outcome. Also included in this concept are the client’s satisfaction, attitude, health-related 
knowledge, and behavioural change regarded as the most important variables in the outcome.  
How the model was adapted to this study 
For the purpose of this study, the elements of Donabedian’s  framework are represented as 
follows: Structure refers to the documents being available to provide continuity of care,  DT to 
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women as documented, cd4 testing documented, DT to baby documented,  the documents of the 
PMTCT care clearly documented for the PMTCT, the availability of the required drugs. These 
will contribute to the outcome and performance of nursing care. The errors, omissions in the 
recording process will affect the outcome (Hoque, 2008).   
The study will be reporting on the activities of core PMTCT activities. The process in this study 
refers to how these activities are performed by the health workers, e.g.  Whether cd4 testing was 
done, the administering of dual therapy, the recording of  the interventions after being 
performed, while all of these activities are to be completely recorded. This also includes the 
provision of continuum care after the records have been documented.  
 The outcome is the result of the care rendered, whether all clients receive the complete activities 
required by the Department of Health, to have been given dual therapy after having tested 
positive for HIV, documents of these activities on the charts to show that this was performed. 
After all these actions have been carried out by the antenatal facilities, the documents should 
show that the care was given. If actions are not recorded, this will mean the care wasn’t 
provided, therefore any errors or omissions will result in a poor outcome.  According to 
Donabedian, (1988) the choice of measuring structure, process or outcome is determined by the 
availability of information. This highlights the importance of having information documented to 
assist in the evaluation, as well as the monitoring of activities of care rendered. The structure 
measures affect the outcome at the end. This will affect the required care that should have been 
rendered, therefore women will not receive the antiretroviral prophylaxis which can lead to a 
long term outcome, that of increasing the chances of the transmission of HIV to the baby. This 
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2.1 Introduction  
The literature presented in this study is related to the Prevention of Mother-to-Child 
Transmission of HIV Program as per the Revised Policy Guidelines of the Department of Health 
- South Africa: PMTCT Manual: February 2008 (SADOH, 2008). The literature was obtained 
through the following databases: Pub-med search, MEDLINE search (1990-2003) - using a 
combination of terms, and Cochrane systemic review articles. The search was based on the terms 
‘Prevention of Mother-to-Child Transmission of HIV’ and  ‘completeness of documents’, 
‘monitoring and evaluation of program’, ‘documentation’,  ‘the use of ARV prophylaxis in 
PMTCT’; the other searches were based on the ‘current infant mortality rate’, ‘the prevalence 
rate in pregnant women of South Africa’ and ‘global interventions on PMTCT’. 
The following sections are presented in this review: 
2.1 The state of HIV and mortality 
2.2 The South African situation for  PMCT 
2.3 Interventions: global and local interventions 
2.4 Monitoring and evaluation 
2.5 Nursing documentation 
2.6  Process of the Prevention of Mother-to-Child Transmission 
The study was conducted when Dual therapy (NVP and AZT) were provided at 28 weeks in 






2.1 State of HIV and mortality rate 
 In the sub-Saharan region, it is estimated that over 90% of new infections among infants and 
young children occur through Mother-to-Child Transmission (UNAIDS /WHO report, 2008). 
Without any interventions, between 20 to 45% of babies may be infected. The overall risk can be 
reduced to less than 2% by a package of evidence-based interventions (UNAIDS 2006).  Mother-
to-Child Transmission of HIV is the highest mode of HIV transmission amongst children in 
Southern Africa, and contributes to child mortality (UNAIDS, 2007). South Africa is one of the 
12 countries globally with increasing child mortality rates (WHO, 2005). Without intervention, 
there is a 35% chance of a pregnant mother passing the virus on to her baby during pregnancy, 
birth, or breastfeeding (UNICEF, 2008). Southern Africa’s under-five mortality rate in 2006 was 
found to be 146 per 1,000 live births (UNICEF, 2008).  
In response to the increased child mortality and transmission rate, countries had made 
commitments based on the United Millennium Development Goals. Amongst others, one of the 
goals was that of reducing Mother-to-Child Transmission by 2015. About 108 countries across 
the world, including South Africa, set targets for the prevention of Mother-to-Child 
Transmission, “ by 2005, to reduce the proportion of infants infected with HIV by 20 % , and by 
50% in 2010” (UNGASS, 2001), which was identified as the leading cause of deaths amongst 
children. Pledges were made by the United Nations Millennium Development Goals (UNMDG, 
2000), Targets 4, 5 and 6, which focus on reducing the child and maternal mortality, “Reduce 
Child Mortality, setting the target: reduce by two-thirds, between 1990 and 2015, to less than 5% 
mortality rate” (UN, 2000). Each country has developed some interventions based on the 
UNMDG of 2000, in the PMTCT. South Africa has adopted the National Strategic Plan (2007-
2011) which amongst other aims includes that of reducing Mother-to-Child Transmission to less 
than 5% by 2011 (DOH, 2007). Having said that, the onus is on each country to have systems in 
place to achieve its target through monitoring of the program performance by conducting 
reviews of charts to identify gaps. Since the running of the study, the PMTCT program has been 
revised for both women and babies’ ART prophylaxis intervention. 
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The PMTCT guidelines revision (DOH, 2010) aim to introduce ART prophylaxis early, (at 14 
weeks as opposed to 28 weeks of pregnancy in women) and to include the new drug called  
Truvada  (Tenofovir) to be given to women during labour. This will also promote early 
attendance at Antenatal clinics, where women will be encouraged by the early intervention.  
Before this, there was only AZT administration at three-hourly intervals, and no intervention of 
Truvada. Also, babies should be receiving Nevirapine within 72 hours after delivery, as well as 
the introduction of a daily Nevirapine dose for six weeks, or for the duration of breastfeeding 
(DOH, 2009). 
Most of the preventive measures to reduce Mother-to-Child Transmission of HIV are through the 
use of Anti-retroviral Prophylaxis drugs and the avoidance of breastfeeding (DOH, 2008). These 
have been proven in developed countries to reduce the risk of Mother-to-Child Transmission to 
less than 2% (UNICEF, 2008). In Europe and the United States of America, the Mother-to-Child 
Transmission rate has been reduced to less than 2% (Newell, 2000). This has been achieved 
through screening pregnant women for HIV, and identifying the HIV positive women who are 
attending Antenatal clinics, early initiation of highly active antiretroviral treatment (HAART) 
while pregnant, delivering by caesarean section, and avoiding breastfeeding.   
The PMTCT Program is provided in all the clinics in South Africa. Although the PMTCT of 
HIV program was implemented, much depends on the documented information by the health 
workers. Documentation plays a huge role in providing continuity of care to clients. Scarf (1997) 
saw patients’ records as a principal source of information of which the nursing documentation of 
patient care is an essential part. Pregnant women living with HIV are at high risk of transmitting 
HIV to their infants during pregnancy, birth, or breastfeeding. Without appropriate care and 
treatment, more than 50% of newly infected children will die before their second birthday (Luo, 
2005). The current transmission rate in South Africa of the Mother-to-Child Transmission is at 
21%, after the single dose Nevirapine intervention, whereas it was 12% without any intervention 
(Rollins, 2008). The National Strategic Plan of South Africa in its strategy for 2007-2011 aims at 
reducing the Mother-to-Child Transmission rate to less than 5% (DOH, 2007). The WHO report 
(2008) has shown an improvement in the provision of antiretroviral for prophylaxis, but not to a 
level that confirms reaching the Millennium Development goals. 
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The figure 1 below illustrates the improvement in the provision of antiretroviral prophylaxis 
from 34% in 2007 to 45% in 2008 (WHO Report: 2008), as well as that of children receiving 
prophylactic treatment from 20% to 32%. The expectation on the run chart below is that if 
women do receive prophylaxis, the same amount of children should be receiving as exposed to 
reduce the transmission rate, ideally one line on top of each other. It implies that women receive 






Figure 2: Showing the proportion of pregnant women and infants receiving antiretroviral 
therapy for prophylaxis 
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A retrospective record review was conducted of antenatal records for syphilis in women 
attending the Prince Mshiyeni Memorial hospital in Durban (Mullick, 2005). This examined the 
compliance with the three doses of syphilis treatment. The study revealed gaps in the recording 
of care, and that the most critical records were either not completed or incomplete information 
was recorded. The gaps resulted in challenges in offering the next level of quality care to 
pregnant women. This study highlighted the need to review records within the department to 
swiftly expose gaps which required correction. 
2.2 The South African Situation context of HIV and interventions 
Prevention of Mother-to-Child Transmission of HIV Program in South Africa 
This is abbreviated as PMTCT and was introduced in 2001 in South Africa in the Province of 
KwaZulu-Natal. The King Edward Regional Hospital is situated in this province. The aim of the 
programme is to reduce the number of HIV infected babies born to HIV positive mothers (DOH, 
2008). 
Mother-to-Child Transmission of HIV can occur through HIV positive women passing on 
infection to their unborn babies (vertical transmission), or through breastfeeding (DOH, 2008). 
South Africa is currently experiencing an overwhelming HIV/AIDS pandemic. In South Africa, 
it is estimated that 100 000 babies per live births became infected with HIV through Mother-to-
Child Transmission (UNICEF, 2004). 
The Prevention of Mother-to-Child Transmission of Human immunodeficiency virus (PMTCT), 
was aiming amongst other things, at reducing the number of infected babies born to HIV positive 
mothers (National DOH Guidelines, Policy Implementation of PMTCT Programme, 2000). 
PMTCT involves methods that reduce HIV transmission during pregnancy, labour and delivery, 
and through breastfeeding.   
Initially, the program had only one drug, this being the single dose Nevirapine (sd NVP), which 
was considered by the World Health Organisation (WHO) as the minimum standard of care for 
pregnant mothers living with HIV, and which was recommended by the WHO.  This was to be 
taken by the mother when in active labour, and given to the infants within 72 hours after their 
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delivery.  The current transmission rate with sd NVP is 21%, high above the expected 12% , 
which was the target for single dose Nevirapine in the PMTCT Program (DOH, 2008). 
The implementation of the program in 2001 did not transpire without controversy. Treatment 
Action Campaign (the activists in support of the provision of antiretroviral treatment) was 
pushing the National Department of Health to commence the PMTCT Program. The National 
Health Department started by piloting the PMTCT program consisting of Monotherapy (sd 
NVP). The TAC felt that the pilots in the 18 sites by the NDOH should be converted to a roll-
out, not only in the 18 sites, but in all state facilities that could dispense it (Bateman, 2007). 
Following a court order, the Department of Health had no choice but to implement the program. 
The TAC won the court order in 2003; therefore the sd NVP PMTCT was spread across all the 
state facilities, not only the piloted sites. The Minister of Health at the time was Minister Manto 
Tshabalala Msimang. She was publicly criticised for delaying revising the sd NVP to Dual 
Therapy, which, according to the TAC spokesperson, Nathan Geffen in 2003 is a scientifically 
proven method of reducing Mother-to-Child Transmission. On 25 January 2008, the DOH 
announced a new national protocol for the PMTCT, namely the introduction to Dual 
Antiretroviral prophylaxis, which consisted of sd NVP plus Zidovudine (AZT). Though the TAC 
welcomed the revised program, they felt it should have included the Lamivudine (3TC), as 
recommended by the World Health Organisation for the PMTCT of HIV, and not just the 
abovementioned two drugs.  For the TAC, another shortfall of the NDOH is that pregnant 
mothers are to be initiated on Anti-Retroviral Therapy, once their cd4 is 200 cells/mm3, or 
below. The TAC feel this is outside current international best practice, because the WHO 
recommends a cd4 count of 350 and below (WHO, 2006). 
According to scientific evidence, the advantage is to initiate ART at a cd4 count of 350 
cells/mm3, and not 200 cells/mm3. The United States and European treatment guidelines 
recommend that all patients including pregnant mothers start Anti-HIV treatment at a cd4 count 
of 350 cells/mm3 . This was not the case in South Africa at the time of this study.  
In 2007 alone, 330 000 HIV positive pregnant women gave birth in South Africa, with the 
estimate that 70 000 of their infants were born HIV positive (TAC Report, 2008). WHO 
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recommends that the full implementation of the revised protocol will reduce the numbers 
significantly (WHO Report, 2008).  
With the use of single dose Nevirapine for the PMTCT programmes, it was later discovered that 
resistance develops with the use of sd NVP, which can compromise the success of the 
subsequent treatment of mother and child with ARV in future.  A study by Newel (2007) on the 
prevalence of resistance to NVP in mothers and children after sd NVP exposure to prevent 
vertical transmission of HIV-1, revealed that there was a high burden of viral resistance in both 
women and children. The sd NVP is considered a minimum standard of care for mothers living 
with HIV who are pregnant.  The Dual therapy revised new PMTCT program, which consists of 
Zidovudine (AZT) and Nevirapine (NVP) which is the recommendation by the WHO (World 
Health Organisation) is considered more effective than the sd NVP (WHO, 2006, Antiretroviral 
Drugs For Treating Pregnant Women). Initially, the WHO had recommended the sd NVP, but 
new evidence is available which supports the effectiveness of the Anti-retroviral (ART) in the 
prevention of MTCT (WHO, 2006). 
This was supported by a study done in Khayelitsha, Cape Town, South Africa, which aimed at 
estimating the efficacy of the PMTCT program in Khayelitsha, and providing details of the 
antiretroviral regimens received by mothers and infants. The results revealed that the majority of 
pregnant women in Khayelitsha accept HIV testing during pregnancy, and are prepared to join 
the program. This acceptance of testing is the key to the effectiveness of the PMTCT program 
(Abdullah et al, 2001). In developing countries like South Africa, on average, less than 10% of 
women receive even the most basic PMTCT services, (Stop AIDS in children campaign) 
therefore access to the PMTCT services remain low.  
2.3 Child Mortality 
Human Immunodeficiency Syndrome (HIV) and Acquired Immunodeficiency Syndrome (AIDS) 
is an epidemic in South Africa. Sub-Saharan countries are the worst affected by the pandemic 
(WHO, 2006).   South Africa is one of the sub-Saharan countries which is most affected by 
deaths caused by HIV/AIDS. In 2004, it was estimated that 10.5 million children younger than 
five years died across the world due to preventable diseases, with the majority of deaths 
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occurring in the poorest countries (UNAIDS, 2006).  In December 2007, 33.2 million people 
worldwide were living with HIV, with 2,5 million people being new infections, and 2.1 million 
dying of AIDS (UNICEF, 2008).  
One of the main causes of death for children younger than five includes HIV/AIDS which 
contributes 40% (MRC, 2000) to the overall deaths.  An estimated 420 000 children were newly 
infected in 2007 (UNICEF, 2008). Without intervention, it is estimated that half of these children 
will die before their second birthday (UNICEF, 2008). In South Africa, according to the 
UNAIDS report, around 5,7 million South Africans were living with HIV at the end of 2007 
(UNAIDS/WHO, 2008). This includes 280 000 children below 15 years of age. In the South 
African National HIV Survey (2005) which sampled a proportional cross-section of South 
African society (15,851 agreed to test), the HIV prevalence rate in men was 8, 2% (6, 342 
males), while the prevalence rate in females was 13, 3% (9, 509). These figures show the 
epidemic in the country of South Africa, with females being the most affected group (UNAIDS, 
2006). 
In October 2008, Statistics South Africa reported on mortality and causes of death in South 
Africa, 2006. It revealed that 91% of the annual number of deaths between the years 1997-2006 
was registered, with 14,783 deaths due to HIV (SatsSA, 2006). These figures were seen as 
underestimates, because most of the deaths were not classified as HIV related. This means that 
most of the deaths are not classified as HIV related, but are classified as caused by diseases like, 
pneumonia, etc.  
Among the number of deaths, WHO estimated that among the countries of the sub-Saharan 
region, over 90% of HIV infections amongst children occur through Mother-to-Child 
Transmission of HIV (MTCT), which is transmitting the HIV infection from the pregnant 
positive mother to her unborn infant, in this way contributing to child mortality (UNAIDS, 
2006).  There is still no cure for HIV; prevention is the main approach to reducing the spread of 
HIV, especially the prevention of Mother-to-Child Transmission of HIV. A report by Professor 
Rollins (Rollins, 2007) on the National AIDS Conference mentioned the increasing child 
mortality in South Africa. In a study conducted in Durban, among 2, 470 infants (6 weeks of age) 
who attended up to 11 different immunisation clinics around KwaZulu-Natal, it was revealed that 
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7 percent of all these infants were already infected by the time they reached the clinic. This, 
according to Rollins, equals the 20,8 vertical transmission rate. Since more than 90% of HIV 
infected pregnant women attend ante-natal clinics, Rollins felt that these women could be 
reached with preventive drugs, like the ART prophylaxis, which is Dual Therapy in South Africa 
(single dose Nevirapine with Zidovudine).  
The PMTCT service delivery in South Africa varies a great deal, with some provinces 
outperforming others, like the province of the Western Cape which has managed to reduce its 
transmission rate to less than 5%. Prevalence studies have been done in South Africa (DOH, 
2007) which estimates the number of South Africans who have HIV. One study by the 
Department of Health, the National HIV and syphilis sero-prevalence survey in 2007, examined 
the Antenatal clinics’ data and used it to estimate HIV prevalence amongst pregnant women and 
Antenatal clinic attendees across all nine provinces of South Africa.  Results showed that in 
South Africa, 28% of pregnant women were living with HIV in 2007 (DOH, 2007). The province 
with the highest prevalence is KwaZulu-Natal at 38.7% (NDOH, 2009) in which it’s the province 
to which the hospital under study falls.  
2.4 Global interventions to reduce MTCT and scaling-up of PMTCT 
According to UNICEF (2008), the HIV epidemic is a major threat to child survival in sub-
Saharan Africa. Almost 90% of global MTCT occur in this region. Southern Africa’s under-five 
mortality rate rose from 125 per 1 000 live births in 1990, to 146 per 1,000 live births in 2006 
(UNAIDS, 2008). More than 400 000 children under 15 were newly infected with the virus in 
2007. Without intervention, there is a 35 % chance that a pregnant woman will pass the virus to 
her baby during pregnancy, birth, or through breastfeeding.   
In 2006, about 39,5 % million people were living with HIV  worldwide, with 17,7 million being 
women, and 2,3 million being children younger than 15 years (UNGASS, 2006). 
A journal article on the Barriers to Access Prevention of Mother to Child Transmission for HIV 
positive women in a well-resourced setting in Vietnam, showed low coverage of the PMTCT 
services ( Shetty, K et al, 2008) .It also investigated the access of HIV infected pregnant women 
to PMTCT services in the capital city of Hanoi. The HIV positive women, who were enrolled, 
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were consulted, in-depth interviews were conducted, and they were asked about their experiences 
in accessing PMTCT services. This study identified gaps in the PMTCT services. Women 
reported being limited by a lack of knowledge and information due to poor counselling. It also 
revealed that HIV testing was done too late for optimal interventions.  Only 44 % and 20% of the 
women had received minimal and comprehensive PMTCT services as revealed by the study 
results. The study managed to identify the barriers to accessing PMTCT services.  
The UNGASS Declaration on HIV and AIDS, 2001 set goals of reducing the proportion of 
infants infected with HIV by 20 % by 2005, and by 50% in 2010, by ensuring that about 80% of 
pregnant women have access to information, counselling and other HIV prevention services, like 
PMTCT, increasing the availability and providing access for HIV infected women and their 
babies to effective treatment to reduce MTCT. 
An effective PMTCT program is needed in order to achieve the UNGASS goal. This study 
reports on the documenting of the PMTCT activities through the reviewing of charts 
retrospectively, where the PMTCT has been revised.  
In another study on PMTCT, “From research to reality” by Sherman (2004), the efficacy of a 
PMTCT program in a routine service setting was assessed. The study utilised retrospective data 
obtained from the hospital records. The study revealed the low HIV transmission rate of 8, 7%. 
The subjects were pregnant women known to be HIV positive who delivered at a hospital in 
Johannesburg. Of the 8,221 deliveries, 1,234 occurred in women known to be HIV infected.  
This transmission rate confirmed the efficacy of PMTCT. They identified the gap in record-
keeping, and felt that it is important that the record-keeping facilitate ongoing monitoring.  
A study on the PMTCT of HIV in resource-limited settings was carried out by Spensley et al. 
(1999) at the University of North Carolina, Washington DC, based on the Elizabeth Glaser 
Paediatric Aids Foundation, in the developing world – to reduce perinatal acquired HIV 
infection. The study reviewed six-and-a-half years of PMTCT programs of HIV. The method 
was for each PMTCT facility to record patients’ data in Antenatal clinics and labour and delivery 
settings regarding counselling, testing, HIV status, and ARV prophylaxis, and to submit the data 
to foundation staff. The results of the study revealed that 92% of the women who received 
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antenatal care had been counselled, and 82,8% of those counselled had accepted testing. Among 
those identified as HIV positive, 75% received ART prophylaxis (which was then sd NVP), and 
among their infants, 45,6% received prophylaxis. The results show that providing patients with 
ART prophylaxis improves program efficiency, as long as the program can be viewed as an 
essential part of the continuum of care.  
 
 In a qualitative study of PMTCT in Khayelitsha, Cape Town, South Africa, gaps in information 
on PMTCT were identified. The study recommended that accurate information is needed about 
PMTCT, including the feeding options and the risks during pregnancy (Chopra, 2000).  
A significant gap remains between global policy commitments to reduce Mother-to-Child 
Transmission of HIV, and access to PMTCT interventions in resource-limited settings like South 
Africa. 
The WHO recommends that using triple therapy (a combination of three antiretroviral drugs) by 
mothers and infants has been shown to reduce the risk of HIV transmission, rather than using one 
drug (sd NVP) (WHO, 2008). In European countries the transmission has been reduced to less 
than 2% (WHO, 2008), but in resource-limited countries, the Dual therapy (AZT and sd NVP) 
has proved to be effective (Alcorn, 2008). 
 A report by UNAIDS (2006) showed that in 2005, less than 10% of HIV positive pregnant 
women had access to PMTCT services worldwide. This implies that a large number of pregnant 
women who required these services did not receive them. With the high burden of HIV in the 
Province, efforts are needed to address the issue of missed opportunities, as women report to 
facilities, and at least more than 90% (Stringer, 2009) attend routine antenatal services.  A study 
by Rollins (2006) on HIV prevalence rates amongst six-week-old infants in South Africa found 
that HIV infected women and infants do not access HIV programs like the PMTCT, due to poor 
identification and an inadequate referral system. The studies revealed the rate of vertical 
transmission at six weeks among HIV exposed babies to be 20.8 % (Rollins, 2006). In Rollins’ 
opinion, to monitor the effectiveness and impact of PMTCT program, the screening of infants at 
immunisation clinics is necessary.   
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According to the WHO Guidelines, the regimen currently recommended for preventing Mother- 
to- Child Transmission in a resource-limited setting like South Africa, is a combination of 
zidovudine AZT and single dose Nevirapine. These were found to be more effective, and less 
likely to lead to drug resistance, as was reported with single dose Nevirapine (sd NVP) alone 
(WHO, 2008). According to the WHO, the women should begin taking AZT at 28 weeks of 
pregnancy. 
In a study on retrospective chart review on the feedback on clinical experience of nurses on 
recording, Hardy (2000) revealed that there are flaws in recording, and that there is a lack of 
prioritised interventions. The study also identified missing information that should have been 
recorded. Currell (2003) looked at the nursing record system and its effect on nursing practice 
and healthcare outcomes. The Prevention of Mother-to-Child Transmission of HIV program is 
one of the interventions that rely solely on the documents compiled by the health workers to 
provide continuity of care.    
 One trial carried out in Zambia (2001) on breastfeeding revealed that there is a problem with 
disclosure of status to partners, or families. In most African cultures, it is expected that mothers 
should breastfeed their babies and women who aren’t breastfeeding are viewed with suspicion.  
This is a big problem here in South Africa too, (UNAIDS,2009) where mothers choose one 
feeding option, then, when they go home their practices don’t permit the choice that they made 
earlier and they therefore alter their decisions, opting for the other method, or mixed feeding.  
 
The information that is provided by the health workers to guide mothers in making informed 
decisions regarding feeding choices is fraught with challenges. The WHO recommended the use 
of AFASS criteria. The choice of feeding for the mother should be based on these criteria. The 
formula powdered milk is being provided by the Department of Health (DOH, 2008) for mothers 
who meet the criteria, and those who don’t meet the criteria have to breastfeed the baby 
exclusively for six months (WHO, 2006). 
While the guidelines by the WHO underline the importance of scaling-up efforts to improve 
exclusive breastfeeding rates for all children to “meet the Millennium development Goals of 
25 
 
reducing child mortality” (WHO, 2009), it still remains a challenge in a society faced with 
stigma and disclosure issues.  
The WHO also recommends that, for HIV positive women, exclusive breastfeeding is 




 Sustainable and Safe  
 The women have to choose the most appropriate feeding option for their babies, but they need 
support to make informed decisions, in order to choose and adhere to the best option for their 
situation (WHO, Geneva, 2009). 
 
2.4.1 The United Nations Millennium Development Goals: 2000 
The Millennium Development Goals were agreed and adopted at the United Nations Millennium 
Summit in September 2000 (UN, 2000). A total of 189 member states of the United Nations 
pledged to achieve the goals within the timeframe. This encompasses eight bound development 
goals, which seek to address the issues of poverty, education, gender, equality, health, the 
environment, and global partnership for development to be achieved by year 2015. 
 Some of the goals set were:  
 Goal 4:  
Reduce Child Mortality, setting the target: reduce it by two-thirds, between 1990 and 2015, to a 
rate of less than 5%. 
Goal 5: 




To combat HIV/AIDS, Malaria, and  other diseases. 
 
In order to reduce child mortality, and achieve Millennium development goal 4, the following 
recommendations were made: 
- Clear documentation of information on HIV, PMTCT, and Anti- Retroviral Prophylaxis 
should exist in the charts. 
- The PMTCT should be up-scaled to prevent further HIV infections, including the 
treatment of pregnant women who need ART. 
- Early identification of mothers needing the ART prophylaxis. 
- Promotion of exclusive breastfeeding in all Antenatal clinics and health care facilities. 
Longer courses of drugs, which involve daily doses for several weeks were found to be more 
effective in Preventing Mother-to-Child Transmission of HIV (WHO, 2006). These  are less 
likely to cause drug resistance.  The adjustment by the National Department of Health (National 
Guidelines, February 2008) for resource-constrained settings like South Africa, stresses the 
added benefit of beginning AZT at week 28 of gestation (DOH, 2008). This will hopefully lead 
to a further reduction of the transmission rate, which is at 21% currently (Evaluation report on 
the PMTCT Programme in 2005) to at least less than 5% with the Dual Therapy (National 
Strategic Plan, 2007-2012), but will also ensure that a smaller proportion of women present for 
delivery, having received more than four weeks of AZT therapy (WHO, 2008; Strategic 
approaches to the Prevention of HIV Infection in infants: report of a WHO meeting, 2003). A 
revised PMTCT program may help South Africa to achieve the Millennium Development Goals 
by reducing child and maternal mortality. This is also because it doesn’t concentrate on the baby 
alone, but also focuses on the mother.  King Edward is a District hospital which has its own 
Antenatal clinic, and also sees clients from feeder clinics which don’t do deliveries, or women 
with complicated pregnancies. The hospital communicates with the Antenatal clinics through the 
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records of the pregnant positive women who come to the clinic with Antenatal cards which 
should contain all the information about the women, including the PMTCT information. 
 
2.4 Access to Anti-retroviral drugs  
2.5.1 Global perspective Access 
In 2005, it was found that only 15% of HIV infected pregnant women received preventive drugs 
(UNGASS, 2001). Botswana, one of the developing countries in the sub-Saharan region has 
managed to lower the rate of MTCT of HIV to less than 4%, along with 15 other developed 
countries (UNAIDS, 2007)  despite systematic bottlenecks, like a human resource crisis.  
Data from the 2005 report card on PMTCT of HIV Care and treatment (WHO and UNICEF, 
2004) found that in 2004, 7 % of HIV positive pregnant women were given Art’s, while 5% of 
HIV exposed babies received the ARV prophylaxis. In 2005, 11% of positive pregnant women 
were given Arts, while 8% of HIV exposed infants received the ARV prophylaxis. 
In 2005, the G8 leaders of different countries agreed to work with the WHO, UNAIDS, and other 
international bodies, to develop and implement “a package for HIV prevention, treatment and 
care, aiming at universal access to treatment for all those who need it, by 2010”. The use of ARV 
as an intervention to “reduce the risk of MTCT of HIV has become an affordable option” as 
stressed by Smith (2003, p. 121) in her thesis on “Some obstacles for the HIV MTCT prevention 
programme”. According to Smith, (2003, p.101) “In order to ensure that programs support  
delivery of PMTCT interventions, it is critical to identify the current and envisaged obstacles that 
could hinder the national initiative of MTCT interventions”. Since it is clear that MTCT 
contributes to child mortality, the obstacles to interventions cannot be afforded.  
The findings of another qualitative  study done in Khayelitsha, Cape Town (Chopra et al, 2000) 
on infant feeding practices emphasised the need for accurate information about MTCT, which 
includes risk during pregnancy, child birth and breast feeding.  
United Political Declaration on HIV and AIDS, June 2006 
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Member states committed to ensuring that pregnant women have access to and receive antenatal 
care, information, counselling and other HIV services. This aimed at increasing the availability 
of and access to effective treatment for women living with HIV and their infants, to reduce 
MTCT. A further aim was to ensure effective interventions for women living with HIV.   
ABUJA Declaration on HIV and AIDS, Tuberculosis and other related infectious diseases, 2006. 
In the Abuja Declaration, Heads of State and Governments committed to achieving the following 
targets: That at least 80% of pregnant women have access to the Prevention of Mother-to-Child 
Transmission.  
Also, that 80% of those in need, especially women and children, have access to HIV and AIDS 
treatment, including ART, as well as care and support.  
A comprehensive research audit of Durban’s four Regional hospitals showed that, despite infants 
accounting for the most paediatric deaths (63%), 75% of all deaths had no information on the 
provision of the PMTCT. Dr Harry Moultrie (2007) Clinician at Chris Hani Baragwaneth 
Hospital)  told the Indaba, at the Aids Conference 2007 that there is a severe lack of 
communication between the Antenatal Care, the Hospital, and the immunisation clinic, which 
meant that  no one has any idea which children have HIV, and which ones ought to receive the 
co-trimoxazole prophylaxis. Both Dr Moultrie and Professor Nigel Rollins (Head of the 
Paediatric and Child Health at the University of KwaZulu-Natal) have shown how badly the 
Health Care system is failing mothers and children. Professor Rollins’ results at the Aids 
Conference, and his research findings revealed a high number of HIV positive pregnant mothers 
at their six week visit to the clinic, and the non-existence of HIV tracking between the Antenatal 
Care check-up at clinics and hospitals.  
Another study carried out by Professor N Rollins (2006), which examined the current system 
efficiency with sd NVP, two tier prophylaxis in KwaZulu-Natal province observed a 92% 
attendance of antenatal care clinics. This implies that women do present at antenatal clinics to 
access antenatal care. 
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The attainment of the UNGASS target of reducing HIV infections by 50% by 2010 necessitates 
that 80% of all pregnant women accessing care receive PMTCT services. In 2005, only 7 of the 
71 countries were on track to meet this target. However, PMTCT coverage increased from 7% in 
2004 (58 countries) to 11% in 2005 (71 countries) (UNGASS, 2006). In 2005, 8% of all infants 
born to HIV positive mothers received antiretroviral prophylaxis for PMTCT, up from 5% in 
2004, though only 4% received co-trimoxazole. 11% of HIV positive children in need received 
antiretroviral treatment in 2005. In 31 countries that had data, 28% of the women who received 
an antiretroviral for PMTCT also reported receiving antiretroviral treatment for their own health. 
Achieving the UNGASS target is possible, but it needs health systems to be strengthened more.  
In 2006, UNGASS reported that at least 8 countries exceeded the 40 % ARV prophylaxis uptake 
mark which is required to achieve the 2005 PMTCT target of UNGASS on HIV/AIDS.  
2.5.2 South African Perspective  
A study in Durban region, by Naidoo et al. (2007) which researched the under-five mortality rate 
in the Durban hospitals, reflected the failures of access to the PMTCT (South African Aids 
Conference, June 2007). It revealed that there are more than 65% of child deaths in hospital 
associated with HIV. This shows that more energy needs to be injected into the health system.  
A study done at the McCord Hospital, a semi-private hospital in Durban, South Africa, by Dr 
Steve Knight (2008) on the effectiveness of the PMTCT program, indicated that a very high 
percentage of mothers received prophylaxis, 97%, and 98% of the babies received prophylaxis. 
This shows the successes of the program in a developing country (SAMJ, June 2008). Amongst 
other factors contributing to this performance, were the effective monitoring and evaluation of 
the data that was available.   
The other crucial core PMTCT which is overlooked, yet which contributes to the transmission of 
HIV is the choice of feeding. Breast milk is another method of acquiring Mother-to-Child 
Transmission of HIV. About 10 to 20 % of infants born to HIV positive mothers may acquire the 
HIV infection (UNAIDS, 2008). Although formula feeding is certainly the correct choice for 
some infected women who meet all the criteria according to the WHO guidelines, exclusive 
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breastfeeding for six months for the majority of the women infected who are poor, reflects the 
balance between the advantaged and the disadvantaged (UNAIDS, 2008).  
 
2.6 Monitoring and Evaluation 
This part will highlight the impact of documentation on quality and on the provision of 
continuity of care in PMTCT. It will also highlight the importance of retrospective chart review, 
as well as effectiveness of monitoring coverage of programs using documents 
In his evaluation of the PMTCT Programme in his 2005 Surveillance Study, Rollins (2006) 
found that the impact of the program depended on the degree of inequities in the health system, 
meaning that providing sd NVP alone was not sufficient to improve the outcomes for both 
mothers and babies. This was later expanded from Monotherapy, sd NVP, due to the fear of 
resistance to a single drug, into the Dual therapy, which the National Department of Health has 
approved, and the current WHO Recommendation (WHO, 2006) consisting of a combination 
regimen of Zidovudine (AZT) to all women with a cd4 cell count greater than 200 cells/mm3 
from 28 weeks gestation, and sd NVP (National Department of Health, February 2008). The 
amended PMTCT protocol shows that this is prioritised as indicated in the South African 
National Strategic Plan for HIV/AIDS 2007-2011, aimed at reducing the Mother-to-Child 
Transmission rates to no more than 5%. The South African HIV Survey (2005) revealed that 
10,8 of all South Africans over 2 years old were living with HIV in 2005. KwaZulu-Natal alone 
was on top with 16.5% prevalence figures compared to the Western Cape with 1,9%.  
 
2.6.1 Importance of documentation 
Nursing documentation continues to draw criticism from professional, community, and 
regulatory organisations because of incomplete, sub-standard charting practices ( Howse et al, 
1990). Documentation is a fundamental nursing responsibility with professional, legal, and 
financial implications. Charting systems have, however, been consolidated to minimise the 
amount of irrelevant data and time spent on documentation. There is a concern that nurses may 
31 
 
be less able or willing to document in ways that reflect the holistic nature of their practice and 
work. Furthermore, questions arise as to whether the clinical record is the best medium for an 
accurate account of nursling’s activities and holistic concerns.  
2.6.2Nursing Documentation perspective  
Much has been written on the content and shortcomings of nursing documentation. 
Documentation has evolved into a nursing practice strategy to monitor and influence health care 
outcomes. Still, barriers to effective documentation have been noted in acute care environments. 
There are three studies have specifically investigated these barriers.  
Renfroe  (1990) reported on the relationship between nurses' attitudes, subjective norms (or the 
influence of others), and behavioural intentions toward documentation. Gathering data on 108 
nurses from three different southern hospitals, the researchers concluded that subjective norms, 
rather than attitudes have the greatest effect on a nurse’s intention to document optimally. They 
recommended communication of high ideals and expectations to the staff nurses from important 
others as ways to enhance optimal documentation (Renfroe et al., 1990).  
Tapp (1990) studied the degree to which nurse’s value documentation, including inhibitors and 
facilitators to this process. She interviewed 14 nurses from a western VA facility, and found that 
complicated forms and unclear language contributed to poor documentation. This research 
concluded that nurses lack professional identity and language, as demonstrated by the 
inconsistent documented evidence of care.  
An audit of charts by Stimpfel (2007) identified numerous important information items missing 
from most of the charts audited. The missing documents were crucial to provide continuity of 
care to the clients, like, medication allergy being left blank, past medical histories, etc. For her, 
the medical documents are seen as important in preventing malpractice litigation, and can be 
used by the health personnel for defence of malpractice lawsuits (Stimpfel, 2007). Clinical 
Records help in planning for patient care, and provide for continuity in information about 
patients’ medical treatment (Stimpfel, 2007) which should be of high quality. 
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A study by Leape et al. (2004) which examined the reasons for errors, found that most of the 
errors resulted from multiple system failures, and staff shortages. Since the care rendered did not 
occur at the same facility, the medical documents give health care members a way of 
communication with each other. If some of the information is not documented, it results in 
blocking the communication, and will interfere with the care the client will receive.   
The PMTCT activities occur mainly through Antenatal services; therefore, documenting from the 
Antenatal care (ANC) is critical for the success of the program. The documented interventions 
received by clients at ANCs guide the intervention at the next level, which is usually the hospital 
where the woman delivers. When there are no documents, actions are not considered to have 
been effected. Complete and consistent documentation is needed to provide consistent high 
quality of care. Documenting on charts serves as proof that the practices were carried out. When 
doing the reviews, an auditor relies solely on the documents.  Monitoring the program at a 
facility level helps to identify the gaps which can be corrected sooner. The Western Cape district 
has localised monitoring and evaluation systems which assist in the assessment of programs, e.g. 
PMTCT , thus monitoring gaps and checking whether the right intervention is provided.  
Documenting on the client card after health worker intervention is an important powerful legal 
document that helps even the health worker when faced with legal issues.  Bjorvell, a PhD 
student in Sweden saw the benefits of documentation as “the improvement of the structured 
communication between the health professionals and also as ensuring continuity of individually 
planned patient care”. According to the WHO (2007), the patient record should include distinct 
and clear nursing documentation, since it contains each patient’s individual needs. Improving 
nursing documentation is important.  Incomplete recording by the health workers indicates that 
the intervention by the next health worker who consults the client will be poor, and further 
investigation will be needed to judge whether or not the care that was given is less.   For 
effective assessment of the PMTCT program, complete documentation of the practice, to see 
whether all the core activities were performed as per the Department of Health guidelines is 
required.   
A study by Henry (2005) in Georgetown, Giyani in South Africa considered the factors that 
influenced women’s uptake of PMTCT interventions. The study identified documentation as the 
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key to PMTCT service provision. The study assessed why health workers did/didn’t document 
complete recommended core PMTCT interventions to prevent vertical transmission of HIV. The 
biggest obstacle to the provision of ARV prophylaxis was the Antenatal care card system which 
is used to communicate to maternity staff the HIV status determined during Antenatal care, and 
every other intervention. The card is a client-held record which the client should bring to the 
maternity section, as most antenatal clinics do not conduct deliveries, but refer clients to the next 
level.  
The United Nations (2000) Millennium Development Goals have recommended that in order to 
reduce child mortality and achieve MDG 4, clear documentation of information on 
HIV/PMTCT/Antiretroviral prophylaxis must be recorded on the charts. To the UN, this can 
increase the scaling-up of PMTCT to prevent further infections. The United Nations considers 
the records crucial in monitoring the program performance to assess how well the program is 
proceeding.  
 
2.6.3 Importance of Monitoring and Evaluation 
The evaluation of the program in 2002 (DOH) across the 18 sites reported that 56% of the 
antenatal attendees were tested, with a prevalence of 30%, while only 55% of these received sd 
NVP, and 99% of HIV exposed newborns received Nevirapine (Doherty, 2005). According to 
UNAIDS report (2008), in 2007, 60% of HIV positive pregnant women had received ARV 
prophylaxis in sub-Saharan Africa. Of these, 39% were from South Africa, while 71% were in 
Europe. Another study by Knight (2005) at McCord hospital revealed that the hospital had low 
transmission rates given the integrated approach, and had managed to provide AZT to mothers 
and babies (75% of the women). A study at Prince Mshiyeni Memorial hospital (Mullick, 2004) 
with a retrospective chart review examined the treatment for syphilis in antenatal care, looking at 
compliance with the three doses. The study revealed that, of the 18 128 records that were 
reviewed, almost two-thirds of the women who completed their treatment, many were missing 
information, e.g. the gestational age. Recording data was found to be the key to monitoring 
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performance, yet limitations existed in terms of the availability of the data on the maternity 
records.  
An audit of the high infant mortality in Durban hospitals illustrates the delivery gap remaining 
for PMTCT and paediatric ART programs (Moodley, 2007). Women were delivering without 
being put on sd NVP.  A report by Blackstock (2008) in a study done at King Edward Hospital, 
revealed that the amount of women who attended the labour ward who were already taking HIV 
treatment was significantly lower. Half of the women who tested positive were found to have 
been recorded as having received sd NVP (Doherty, 2007). This gap can be closed if women are 
put on ART prophylaxis as per the guideline, and this treatment is documented in patient-held 
charts.  Good documentation reveals good patient care, so, by reviewing charts, patient care can 
be improved through identifying gaps, and providing ideas to correct bottlenecks.  
Countries like Botswana and Brazil have managed to provide PMTCT services to most of their 
pregnant women. Botswana has reduced Mother-to-Child Transmission to less than 2% 
(UNAIDS 2005).  
A Cochrane search was done on Anti-retroviral for reducing the risk of MTCT of HIV infection 
in South Africa, Cape Town. The objective was to determine the extent of Anti-retroviral aimed 
at decreasing the risk of MTCT of HIV infection, and also, whether they achieve a decrease in 
the transmission risk, and the effect these interventions have on maternal and infant mortality 
and morbidity. The first trial began in 1991, and assessed Zidovudine versus a placebo. These 
studies revealed that AZT was more effective than the placebo. After these results, there were 
modifications of the dosage and duration of the drugs. Regarding the other studies on ARV vs. 
placebos in the breastfeeding population, three studies revealed that Zidovudine given to mothers 
from 36 to 38 week gestation, during labour, and for 7 days after delivery significantly reduced 
HIV infection at 4 weeks (efficacy 32%). 
2.7 Process of Prevention of Mother-to-Child Transmission 
This section outlines the process of PMTCT as provided in each area of maternal care, from 
antenatal care, labour and delivery services as well as post-natal care. Each area of maternal care 
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for PMTCT is critical to happen, multiple activities in each step provided in different settings 
(from antenatal services through to post-natal service provision to mother and baby).   
• Ante natal Care: 
Pregnant women presenting for antenatal care should receive Voluntary Counselling and Testing 
for HIV. Women who agree to be tested and are discovered to be HIV positive, should be WHO 
clinically staged, as well as subjected to cd4 count testing, and all this should be documented on 
the Antenatal chart. Antiretroviral prophylaxis, Dual therapy, which contains Zidovudine (AZT), 
and sd Nevirapine should be taken by all pregnant HIV positive women. The sd NVP 200mg is 
given to the pregnant mother to keep, so she should take it when she is in active labour, but the 
AZT is given from 28 weeks gestation period onwards. The AZT dose is 300mg twice daily, 
until she is in labour. If results for the cd4 count are 200 or below, (the count usually comes back 
within a week or more, depending on the facility’s turn-around time) the woman should then be 
switched from DT to Anti-retroviral (Highly Active Anti-retroviral Therapy-HAART), from the 
ARV initiation site, which is not usually the Antenatal clinic, but the hospital. The initiation of 
HAART should take place after a client has done three classes called Literacy classes, which are 
readiness classes that promote compliance. The feeding option is discussed with the woman so 
that she can make an informed choice based on WHO AFASS criteria.   
• Onset of labour 
Women presenting with labour records are checked into the labour ward, from the ANC card 
used while at ANC, if the client is on the PMTCT program. If the records don’t show the 
PMTCT information, the woman is considered to have an unknown status.  She is then asked 
whether she took the sd NVP 200 mg before coming to the hospital. If she did not, she will be 
given this drug from the hospital supply with AZT 300mg immediately, and three-hourly doses 
of AZT thereafter until she delivers.  This will be recorded in the maternity records.  
• Post delivery 
The infant receives sd NVP 2mg/kg within 72 hours after delivery. The infant will then receive 
AZT 4mg/kg twice a day for 7 days if the mother had received AZT for more than 4 weeks. If 
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the woman received AZT for less than 4 weeks, the infant will receive AZT 4mg/kg twice daily 
for 28 days. This 28 day dosage of AZT to the infant applies if the woman was on HAART for 
less than 4 weeks with a low cd4 count, or WHO clinical stage 4 was recorded on the Antenatal 
card. When the woman is discharged, she takes with her the AZT for the baby for prevention of 
transmission. Post-natal care for the woman and her infant is done at the local clinic which the 
study didn’t cover.  
2.8 Conclusion 
This chapter highlighted the prevalence of HIV, the current status of the PMTCT program, the 
importance of and issues surrounding documentation. The key areas that needed to be focused on 
in order to improve access to anti-retroviral treatment as well as prophylaxis, to improve child 
and maternal child survival are documented. the global as well as the South African perspective 
of the study question. It showed that drugs were never the issue, but that there are gaps in the 
provision of intervention for the program which lead to Mother-to-Child Transmission. It also 
highlighted the importance of documenting the intervention for quality of care to clients and 




 RESEARCH METHODOLOGY  
4. Introduction to the methods 
Methodology, according to Cresswell (2009), is an approach to enquiry providing specific 
directions for procedures in a research design. It helps to focus the inquiry on the research 
design, in trying to find answers.  This chapter will explain and describe the research design used 
in the study, the setting, population and sampling technique used to obtain the sampled patients’ 
records. The data collection process, data extraction tool, data analysis, data management and 
ethical considerations are also presented in this chapter. 
5. Research Approach  
This research study was based on the Positivistic paradigm. Under this worldview, the 
quantitative approach is applicable. The philosophers subscribing to this paradigm make 
assumptions that the facts and truth will be uncovered through numbers, and can be objectively 
observed by a careful statistical measure of relationships whilst recording observations. The 
Positivists’ findings of the results (Polit and Beck, 2008) will not be influenced by the 
researcher. Objective observation of the phenomena, whilst trying not to interfere with 
observations. The paradigm emphasises observation and reason as a means of understanding 
human behaviour, thus it is used to generate knowledge. The paradigm will help in an accurate 
description of the guidelines, aiming at explaining events.   
The positivistic view is suitable for this study as it reports objectively, in numbers, rather than 
words on the relationship observed between quantitative variables, and provides a description of 
what observations can be discerned in the relationship amongst the variables. This part will be 
presented quantitatively; a quantitative approach is therefore suitable for this study.  
3. 3 Research Design  
A non-experimental retrospective descriptive exploratory design informs the study. This study 
aims at providing a description of how the core activities of the PMTCT are carried out, 
presenting and discovering the relationship amongst the variables. For Cresswell(2009),it allows 
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observation and documenting aspect of situation as it naturally occurs, without manipulation. 
The use of retrospective records is suitable for the study as it will indicate with clarity whether 
the program activities are implemented as planned (Hess, 2004).  
3.4 Research Setting 
 The research was carried out at a Regional Hospital in South Africa, KwaZulu-Natal province. 
The hospital is one of the largest hospitals in the South of Durban. It is a 922-bedded hospital 
and is situated in Ward 33 in Ethekwini district. It is based in an urban setting, and is 
government-funded, including a rural and semi-rural setting. The hospital covers a wide 
catchment area with an estimated 500 deliveries per month (DHIS, 2010). This hospital is also a 
teaching hospital of the University of KwaZulu-Natal’s Nelson R Mandela Medical School, and 
has a Nursing College for Advanced Midwives (KEH Database). It is a public service with a free 
service offered to pregnant women. 
3.5 Study population 
The study population according to Brink (2006) is defined as the entire group of people or 
objects that are of interest to the researcher, or that meet the criteria the researcher is interested in 
studying. The total number of deliveries in the hospital is estimated at 500 per month (DHIS, 
2010). The sample population was all the patient records that meet the inclusion criteria for the 
study. 
3.5.1 Inclusion Criteria 
The selection of inclusion criteria was based on the study objectives, and the questions that the 
study wanted to answer. All charts of patients who delivered between the periods 01 April to 30 
July 2009 were considered for selection. The inclusion criteria for the study were as follows:  
i. HIV positive clients who were pregnant. The interest for the study is on the Prevention of 
Mother-to-Child Transmission, which applies to HIV tested positive clients.   
ii. Booked cases with four or more Antenatal Clinic visits. This was chosen to allow equal 
opportunities for the activities to have been carried out by the antenatal clinics. 
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iii. Public sector facilities.  
The public health sector was chosen because they were offering a package for Prevention of 
Mother-to-Child Transmission of HIV, as described by the Department of Health guidelines 
(2008). 
iv. Had been issued with client-held/patient-held records while pregnant (records of antenatal 
clinics). 
v. Delivered in the facility and not at home. This variable was chosen based on the PMTCT 
interventions that are only available in the delivery setting and which should not have been 
available at home. 
vi. Not already on Highly Active Antiretroviral therapy (HAART). Clients who are already on 
HAART (Highly Active Antiretroviral) do not follow the same activities as those who are newly 
tested and are not on treatment.  
 3.5.2 Exclusion criteria  
The exclusion criteria are all the characteristics which are not listed in the inclusion criteria 
above.  
3.6 Sampling procedure 
3.6.1 Sample selection 
 According to Brink (2006) a sample is a part or fraction of a whole, or a sub-set of a larger set, 
selected by the researcher to participate in a research project.  Sampling refers to the selection of 
materials so that the selected group is representative of the population the researcher is interested 
in (Creswell, 2009). The sampling in retrospective chart review refers to the method by which 
records are selected from the targeted population (Cresswell, 2009) which in this instance meant 
all of the charts of pregnant women delivered in the hospital between the period  01 April 2009 
to 30 July 2009  at the Medical Records department were included for sampling. There were 
1800 (N=1800) deliveries during the period between 01 April 2009 and 30 July 2009 (DHIS, 
2009) at King Edward V111 Hospital. Of these deliveries, 7% was considered an adequate 
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sample size for the study. This is based on a previous study by Doherty (2008), and on the type 
of research used, namely, a descriptive study.  
A simple random sampling was used to select the charts from the period of interest as mentioned 
above. A simple random sampling according to Brink (2006), allows everyone the opportunity to 
be selected, which permits a representative sample. The registered numbers as opposed to the 
names of pregnant women were used to draw the sample. From the list of registered numbers, 
patient records were selected based on inclusion criteria. Then simple random selection to avoid 
bias.  From the 1800 charts that were selected only 130 charts met the criteria. This was due to 
the inclusion criteria that the researcher was interested in, e.g., the HIV status, whether any 
antenatal clinic was attended more than four times or not, or not at all, and how many bookings 
there were. To control for the sampling bias, only the characteristics for the study in the inclusion 
criteria were used to select the sample.   
3.6.2 Estimating the sample size 
The hospital has approximately 400 to 500 deliveries per month (DHIS: 2010). All the charts of 
previously pregnant women who had delivered at the King Edward V111 hospital during the 
period 01 April 2009 to 30 July 2009 comprised of 1800 deliveries in total.  Based on this 
number, selection criteria of eligible charts were based on inclusion and exclusion criteria. A 
total of 130 charts met the set criteria to be included in the study, therefore considered sample 
size for the study. The rational for this sample size is that the study aims at providing a 
description of the process of prevention of mother to child transmission. This sample is adequate 
to answer the research question, and that it represent charts that met the criteria for selection.   
 
3.6.3 Data collection instrument 
A data extraction tool (Appendix 3) was developed for this study to be used for data collection.  
The extraction tool consisted of the demographic variables, which included the age, the marital 
status, the employment status, type of delivery, and the time taken from booking in to testing, the 
baby’s weight, and the number of staff on duty. These binary variables were used, based on the 
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previous studies that had used them to discover relationships. Part two of the extraction tool had 
all the variables of the Prevention of Mother-to-Child Transmission of HIV. This was used, 
based on the Department of Health’s guidelines (2008) on which this study is based, to indicate 
which activities were to be included, and regarded as of importance in the coverage of an 
effective PMTCT program.   
 3.7 Data collection Procedure 
Permission to use the charts was obtained from the hospital Chief Executive Officer for King 
Edward Hospital. A request for permission letter from the Chief Executive Officer was submitted 
to the Medical Records department where the patient records are kept for filing. The copy of the 
consent from the Chief Executive Officer was kept at the Medical Records department for filing. 
 Data was collected, guided by the standard data abstraction tool (Appendix 3)  to inform the data 
collection process which had been developed for the study to extract data from the patient 
records containing all the variables to be collected, by examining the documented activities from 
the time the women had attended antenatal clinic. The researcher extracted the data. The data 
collection included the following variables as Part One of the extraction tool: demographic 
variables (age, marital status, employment status, birth weight and type of delivery - as outlined 
in the table of demographics, Appendix 1, Part 1 – extraction tool). The core PMTCT activities 
were the second set of variables which was developed, based on the PMTCT guidelines (DOH, 
2008) and previous studies done (Horwood, 2010) which outlined the activities needed for 
prevention of Mother-to-Child Transmission of HIV, and identify the key activities as outlined in 
the table of variables (Appendix 1, Part 2) .  
A convenient time to conduct the extraction was requested from the Medical records team, which 
turned out to be between 14h00 to 16h00 pm at the Medical Records department, at King 
Edward Hospital. Mondays, Wednesdays and Fridays were dedicated for extraction (three times 
a week). A total of ten charts were reviewed a day. This was the request of the Medical Records 




3.8 Reliability and Validity of the study 
3.8.1 Inter-rater reliability: 
To ensure inter-rater reliability, the data extraction tool was piloted to test whether the same 
results would be achieved with repeated use. According to Yawn (2005), information on the 
inter-rater reliability is seldom reported. The same standard tool was used for both charts. The 
inter-rater reliability is measured as a percentage of agreement when two or more abstractors 
collect from the same chart (Allison, 2000). This was achieved by using five charts and using 
two raters. The raters included all the categories of Data Abstraction Tool Two from 
demographics, two variables from Part 2 of the extraction tool which look at the PMTCT 
activities, and lastly, the PMTCT information location. The coefficient from the two raters 
revealed the need for refinement and the addition of at least two variables that looked at the 
relationship to answer the research question. The correlation coefficient was -1, and was not in 
agreement; therefore the tool had to be refined.  
Results for raters 
i. Dual  therapy to mother at Antenatal clinic 
ii. Cd4 testing for mother 
The percentage difference between the two raters was 5%, where for dual therapy one chart 
hadn’t recorded Dual therapy at antenatal care, while the other did not have records. In both 
charts, the second rater, the cd4 was recorded to have been taken, but one hadn’t captured results. 
The difference between the two was not due to the tool not being able to capture information, but 
was the result of poor performance as the study aimed at ensuring that charts documented the 
activities.   
3.8.2 Content validity 
This is an assessment of how well the instrument represents all the different components of the 
variable to be measured (Brink, 2006). To ensure that all components were measured, the three 







Table 3.1. Confirming the content validity of the tool: 
Objective How it was met 
I. To describe the processes of PMTCT 
activities as documented in the charts  
II. To assess the performance of 
PMTCT activities by providing the 
proportion of charts with complete 
documented PMTCT core activities as per 
revised PMTCT guidelines. 
III. To explore the relationship amongst 
the core activities of PMTCT as 
documented in charts  
 
 
Part B , all the activities that should be carried 
out are described ( thirteen core PMTCT 
activities ) 
 
Part A and B   
 
 
Part A  (8 demographics), B  (13 activities) 
and C (legality of the charts) of the extraction 
tool answers the objective 
 
3.9 Data extraction and Data management 
The standard data extraction tool was used as the gold standard for consistency in data recording, 
and only the researcher conducted the extraction. For quality assurance purposes, the data 
collection process was assessed once in three days. The quality assurance included checking for 
the three variables’ responses in the tool, to assess whether the tool was collecting what it 
intended to collect, with the same wording of the variables.  An extraction tool was standardised 
for all of the 130 charts’ data extraction. To improve the extraction process, the researcher used 
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an exemplary chart showing the relevant information to be used as a reference for abstraction 
which was displayed in the room used for extraction. The extracted data would not be used other 
than for the purpose of the research. Only the researcher and the research supervisor would have 
the access code for data access. Data will be discarded after five years. 
3.9.1 Missing charts   
No charts were found missing. This reduced the bias that might have been caused by the missing 
files.  
3.9.2 Missing data 
 Data that was missing was managed as ‘not done’. This is because it is critical for every client to 
have recorded activities of PMTCT from the Antenatal care facility, to provide a continuum of 
care to the delivery site. If this was missing, it was deemed not to have been done.  
3.9.3 Measurement error 
The data extraction was piloted on five charts to ensure that the instrument (data extraction tool) 
gathered the information that was to be collected. The pilot resulted in a positive outcome, with 
all the variables of interest covered, as well as the demographic data. 
 3.10 Ethical Consideration 
The research was conducted in an ethical manner. The record review did not record nor link to 
identifiers, i.e., the names or the identity documents of the records were not collected in the study 
but the study simply extracted information required for the research. Permission to review 
records at the King Edward hospital was obtained from the Hospital Manager (Annexure1 and 
Annexure 2).  
Information was provided to the hospital Chief Executive Officer, which detailed the reason why 
the study needed to be conducted. The records used for data extraction were guided by the 
extraction tool, and were not used for anything other than that. There was a fair selection of 
participants; the selection was based on reasons directly related to the study by using the 
inclusion criteria.  
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Confidentiality was ensured by not mentioning the patients’ names. They remained anonymous. 
This was achieved by coding the patients’ charts; therefore the data for the participants would 
not be linked to their names. The study may be published, but it will not use personal identifiers. 
Ethics clearance was sought from the Biomedical Research Ethics Committee before the study 
was conducted, and permission to conduct the study and consent was obtained from the Hospital, 
pertaining to permission to use the medical documents of pregnant positive women who had 
delivered in that hospital. Consent was not sought from the pregnant women, as only their charts 
were used.  Personal identifiers were stored in a separate location for confidentiality.  
 
3.11 Dissemination of findings  
The findings of this study will be published through the University of KwaZulu-Natal library, in 
consultation with the supervisor. A copy of the report will also be submitted to the hospital Chief 
Executive Officer as agreed.  
3.12 Data Analysis  
For Polit (2008), data analysis is a process which a researcher coherently organises and 
synthesises. The data was analysed based on the research question, and objectives. A description 
of demographic characteristics will first be provided, which will be followed by the description 
of the variables, and activities of interest which are considered the core activities for the 
Prevention of Mother to Child transmission of HIV. Non parametric tests will be used in data 
analysis .The use of non parametric tests namely Pearson’s Chi square, Fischer‘s exact, Kruskal 
Wallis-was used to discover the relationship amongst the study variables 
Data Analysis was done using computer program SPSS (Statistical Package for Social Sciences) 







This chapter covered the methodology used to guide the study; the instrument used to collect 
data, and included the ethical aspects on protection of the participants for the study, the control 





















Data Analysis and Presentation of Results   
The chapter will present the analysis of data of the retrospective review of patients records 
conducted at the selected regional hospital  A description of demographic characteristics will 
first be provided, which will be followed by the description of the variables, or activities of 
interest which are considered the core activities for the  Prevention of Mother to Child 
transmission of HIV. The use of non parametric tests namely Pearson’s Chi square, Fischer‘s 
exact, Kruskal Wallis-was used to discover the relationship amongst the study variables. Each 
chart assesses whether all the core activities of PMTCT is documented which will be shown by 
the documents on charts. A decision was made that if the charts do not have the documented 
activity, that will be taken as not done. This is based on the study done (Town-send et al: 2007), 
which stresses the importance of documentation by the health workers to assist in the provision 
of continuum of care to clients. 
 
4.1 Introduction 
All the 130 charts met the inclusion criteria thus considered for analysis. Data was analysed 
based on data collected from the extraction tool developed for the study guided by the PMTCT 
key activities (DOH: 2008) from the patients records. Analysis was done using computer 
program SPSS (Statistical Package for Social Sciences) (Version 15.0, SPSS Inc., Chicago, IL) 
as well as Microsoft excel.  
The Chi square is the most widely used statistical test in nursing research (Brink: 2006), used to 
compare set of data, in the form of frequencies.  The performance of these statistical tests is to 
discover the relationship between the core PMTCT activities amongst themselves, as well as the 
relationship of the activities with the demographic data. Proportions, frequency tables, and 
graphs (bar graphs, pie charts) will also provide the description whether PMTCT is provided in 
the services. A decision will be made based on clinical significance of the results. The aim of the 
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study was to assess whether core PMTCT activities are provided the hospital of Kwa-Zulu Natal, 
Durban as documented in the charts.  
A description of demographic characteristics will first be provided, which will be followed by 
the description of the variables used.  
 
4.2 DEMOGRAPHIC CHARACTER ISTICS OF THE SAMPLE 
A total of eight demographic variables were used in the study, namely: age, marital status, 
employment status, type of delivery, time taken from booking to testing, parity, baby birth 
weight, staff on duty. These variables were selected based on the previous studies that considered 
these important in discovering the relationships with the activities of Prevention of Mother to 
Child transmission of HIV program Horwood (2010)  
Table 4.1: Sample Characteristics 
Characteristic Frequency Percentage 
 
Age group 
13 years to 19 years 
20 years  to 26 years 
27 years to 32 
33 years to 38 
39 years and above 
Mean  = 24.8 















Mode = 19  
Range= 14 – 47  
Median = 23 years 
 
Marital Status  
Single       
Married    














Booking to Testing 
At first visit 































Staff on duty 
Less than 10 RN  
More than 10 
Mode of Delivery 















Above 1,5 kg 









4.2.1 AGE DISTRIBUTION 
The sample reflects the age distribution of women that delivered in the Regional hospital as 
documented on patient’s records. The youngest participant was 14 years and the oldest was 47 
years of age. The mean age was 24.8 years, standard deviation = 7.07 with a mode of 19 years. 
When age was grouped, the majority of participants fell within the category of 20 to 26 years of 
age, n= 41(32 %), followed by n= 37(28%) within the 27 to 32 years and n= 36 (28%) total 
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falling within the age group of 13 to 19 years respectively (see table 4.1).  It is evident that 
women that were pregnant at the time of study were ranging between this age group. Twelve 
women fell within the age category of 33-38 years of age n=11(8%), whilst the participants in 
the category of 38 years and older were n= 4(3%). Majority of participants were 19 years old (i.e. 
n= 14 (11%), whilst only 1 (%) participant was 47 years of age.  
 
Figure 4.1: Age distribution of participants 
4.2.2 Marital status  
Marital status was categorised into four, namely single, married, widowed, and divorced. All 
reviewed charts had documented marital status. Of the charts reviewed, the majority had n=97 
(75%) participant single, followed by n=32 (24%) documented to be married. Only n=1 (0.8%) 
was a widower whilst no one was reported to be divorced as per documents. 
4.2.2.1Marital status and age  
The minimum age of clients that were reported single n=97 (75%) was ranging between 14 to 35 
years, median was 22. Of the n=32(24%) participants that were married, the minimum age was 
19, maximum of 47 years, with a median age of 37. This implies that most of the sample was 
made up of young single women.  
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On investigating the relationship between age and the marital status using the  Kruskal Wallis 
non parametric test,  no significant relationship was established between these variables 
(Kruskal-Wallis H value= 28.23, d f= 1, p= 0.234). This result suggests that the participant’s age 
had no relationship with regards to her marital status in this study. Although a significant number 
of charts reviewed were those of single women between ages 14 and 35 years, which may 
indicate high prevalence of HIV in this age group in women whose charts were eligible for 
inclusion in the study.  
Table 4.2.  Comparing means between marital status and age range 
Marital 
Status 
N % Age Range Median 
age  
Mean rank 
Single 97 74.6% 14—35 years 22.00 53.40 
Married 32 24.6% 19-47years 31.50 100.36 
Widowed 1 0.8% 37-37yeras 37.00 123.0 
Divorced 0 - - - - 
 
4.2.3 Employment status 
This variable was recorded employed or not employed in the charts; therefore it was reported in 
the study as the binary variable. The documents could not specify what type of employment. A 
total of n=30(23%) participants were employed, with n=100(77%) without employment. This 
demonstrates that only a quarter of women delivering in this hospital have employment.   
4.2.3.1 Employment status and marital status 
A cross- tabulation of marital status and employment revealed that more than two thirds of the 
sample were single and unemployed (n= 85, 65.4%), in relation to only n=15 (12%) of married 
women who were unemployed. Table 4.2 displays the results of the cross -tabulation. When 
employment status and marital status was assessed using a Pearson Chi Square test showed a 
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significant relationship between these variables ( x 2 = 25.87, d f=  2, p= 0.000 ).These  results 
suggest that employment status is related to a participant’s marital status. 
Table 4.3: Employment status and marital status cross tabulation    
Marital status Employed  Not employed Total  
Single 12 (9%)  85(65%) 97(75%) 
Married 17(13%) 15(12%) 32(24%) 
Widowed 1(0.8%) 0(0%) 1(0.8%) 
 
4.2.4 Type of delivery and administration of Nevirapine to the baby 
This binary variable of whether the delivery type was Caesarean section or by normal vaginal 
deliveries variable was chosen because some babies may have not received Nevirapine dose 
(prophylaxis), because the child was delivered with complications. In the public health sector, a 
caesarean delivery is only performed when there is an indication. ( Moodley: 2005).  The normal 
vaginal deliveries were n=74(57%), whilst participants delivered by a caesarean section were 
n=56(43%). This entails that in this study, participants delivered normally were slightly more 
than those delivered by a caesarean section.  
On further exploration between the mode of delivery and the administration of Nevirapine using 
a Fishers Exact non-parametric test, there was no significant relationship established (Fishers 
exact value= 2.492, d f= 1, p= 0.114). This is an encouraging finding which suggests that the 
administration of the NVP is not affected by the mode of delivery.  
4.2.4.1 Baby birth weight and type of delivery 
This variable birth weight was used as a proxy measure to estimate whether low birth weight 
(below 1,5kg) and normal birth weight (equal and above 1,5 kg) relates to the type of delivery 
for  women. About n=82(63%) of babies had the birth weight of 1,5 kg and above whilst  
n=48(37%)  had the weight below 1.5 kg. This implies that most babies had the birth weight of 
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1,5 kg and above respectively. The number born with normal weight outweighs the babies born 
with low birth weight by n=34(26%).  
On exploration of the relationship between the babies birth weight and the type of delivery using 
a Chi square test, there was no significant relationship established (x2 value=0.487,d f=1, 
p=0.272), implying that a child’s birth weight is not affected by the mode of delivery ( either 
normal vaginal delivery or caesarean section) of  a woman. 
 
 
 Table  4.4 : Birth weight (below or above 1, 5 kg) and type of delivery (Caesarean section 
and Normal vaginal delivery). 
 Type of delivery 
  
Birth weight  





















4.2.5 Parity and Nevirapine to pregnant women 
This binary variable assessed whether the current pregnancy was the first pregnancy or not the 
first pregnancy. About n=50(38%) participants reported to be pregnant for the first time, whilst 
n=80 (62%) was not the first pregnancy. This implies that more than half of the  participants 
were not pregnant for the  first time in this study. This variable will be used to investigate the 
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relationship between the administration of Nevirapine to the women and the parity. On 
application of Chi square, a non significant test result was obtained ( x 2 = 6,923, DF=1, 
p=0.009) which suggest a non significant relationship between the participant’s parity and the 
administration of Nevirapine to a woman. 
4.3 Activities of PMTCT 
To assess the performance of PMTCT, fifteen activities were identified as the core activities that 
will inform that the women and children received the antiretroviral prophylaxis as per DOH 
(2008). This entails that if the program is implemented well, each patient document should have 
all the activities documented. Given the fact that every activity or intervention to prevent mother 
to child transmission is important, some charts were found to have gaps on important areas. This 
may mean that there were gaps in the provision of quality care for prevention of mother to child 
transmission of HIV. The list of  the activities were as follows: 
I. Dual therapy (DT) initiated at Antenatal clinic 
II. DT taken more than four weeks 
III. Single dose Nevirapine taken in labour 
IV. AZT 3 hourly taken in labour 
V. Cd4 count taken 
VI. Cd4 results documented 
VII. Cd4 count Below 200 
V111. Above 200 cell count 
1X. HAART initiated during pregnancy 
X. World Health Organisation clinical assessment (WHO Staging) 
XI Infant feeding counselling  
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X1I.Formula feeding choice  
X1I1.  Breastfeeding choice 
X1V. AZT  to baby within 72 hours 
XV. DT to baby to be given at home 
4.3.1 Dual therapy initiation to pregnant women 
 About n=98(75%) of charts showed that dual therapy was initiated while pregnant with 
n=43(33%) had it taken for more than four weeks. These results suggest that there is an 
improvement in the coverage of dual therapy initiation to pregnant women, which is contrast 
with a study by Doherty (2009) which showed reduced uptake at 57% of DT at antenatal care.  
About n=91(70%) had a single dose Nevirapine taken in labour. Participants documented to 
taking AZT three hourly were n=81(62%) respectively, whilst n=91(70%) of women 
documented to have taken single dose Nevirapine (sd NVP) in labour. The descriptive findings 
of this variable suggest that pregnant women were 75% more likely to receive Dual therapy 
while pregnant. 
4.3.2 Dual therapy initiation to baby 
A total of n=105(80%) of babies born to HIV positive women received nevirapine post delivery 
whilst n=95(73%) received AZT within 72 hours after delivery as required by the Department of 
Health program guidelines. This study showed much improvement when compared to the study 
by Doherty (2009) which showed 15% of nevirapine to babies. The results suggest that babies 
are 80% more likely to receive dual therapy when born to HIV positive women in this study. 
4.3.2.1 Relationship between Dual therapy to women and Dual therapy to babies 
documented 
A total of n=98(75%) of sd Nevirapine given to mothers while n=105(80%) sd Nevirapine was 
recorded as administered to babies. This  indicate the 5% difference between the baby NVP and 
the mother NVP. Although it seems like there is improvement in the administration of NVP to 
babies, compared to Doherty (2009) study of 15%, but the 20% is too large the proportion for the 
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babies that were missed. Newell (2007), had stressed that one life lost is too many, if the 
opportunity for administration are missed. This entails that these babies maybe at increased risk 
of transmitting the virus from their mothers if they didn’t receive antiretroviral intervention 
prophylaxis. Interestingly, there were no set of twins in the charts that were reviewed; hence it 
was not in the exclusion criteria. On exploring the relationship between the dual therapy to 
women and a dual therapy to babies applying Fischer’s exact test (Fischer’s exact value= 0.19, d 
f=1, p= 0.66), there was no significant relationship established between DT given to women, and 
the DT given to babies, this is of concern on light of the guidelines (DOH: 2008) , a difference as 
indicated by the fisher exact test suggests that not all mothers and or babies are receiving the 
dual therapy as is indicated  
 
4.3.3 CD4 Recording  
4.3.3.1 Relationship between CD4 taken against cd4 cell count results documented 
A total of   n=78(60%) had cd4 taken, while n=52(40%) of eligible positive women were not 
taken cd4 count.  Of the participants taken cd4 cell count, only n=45(35%) had their results 
documented. A cd4 cell count is the requirement that all HIV positive women to have been taken 
same day of testing for HIV ( Doherty : 2009).  This enables women to be able to assess for 
eligibility for lifelong antiretroviral therapy (ART) when their cd4 count is equal or less than 200 
cell count (DOH: 2008), which help them to improve their own health. Having a cd4 count that 
is less than 200, poses risk of transmission from the pregnant woman to her unborn child 
(Dhayendre: 2007). This study result is in contrast with the study by Horwood (2010) which 
discovered much improved uptake 78% of cd4 taken. The documentation of results or 
availability is still a gap in this study ( 35%) compared to Horwood study which showed 
improvement by half (55%). 
A Fischer’s exact test exploring the relationship between the cd4 taken and the results 
documented revealed no significant relationship ( Fischer’s exact value = 19.23, df=1,  p= 0.028)  
This indicates the likelihood of a disparity of a client having their cd4 test performed and not  
receiving results for the cd4 test. 
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4.3.3.2 Booking to testing against cd4 count taken 
About n=52(40%) of women who were booked for their first antenatal visit were tested for HIV   
on the same day of booking compared to n=78(60%) who were tested on repeat visits.  One of 
the exclusion criteria has been that women should have at least attended the antenatal clinic four 
times or more (this was done to control for clients who may have booked late and would have 
not been able to access antenatal care early to receive the package). This reveals that there still is 
a gap in clients being tested at the same day of booking. Although the testing is voluntary, which 
means a person chooses to be tested after having pre test counselled; there was no record of the 
test being offered to clients and whether they refused the test. The delay in testing worsens the 
cd4 resulting which should be taken the same day of testing HIV positive (out of the n=78(60%) 
done cd4, only n=39(30%) of them were done same day of testing positive.  
A non significant test was obtained when applying a non-parametric test (Fischer’s exact= 0.39, 
d f=1, p= 0.335) . The results suggest that there was no relationship between the time the 
participant book for antenatal care and testing for cd4 cell count, this is of concern in light of the 
PMTCT guideline which indicates that (a cd4 test should be done the first day a participant test 
positive.  
4.3.4 HAART initiation during pregnancy 
4.3.4.1 Relationship between Cd4 results <200 mmol/l and HAART initiation 
About n=18(14%) had a cd4 cell count of less than 200 mmol /l. Of the clients with low cd4 cell 
count, n=10(55%) were initiated on Highly Active Antiretroviral Therapy while pregnant 
(eligibility as determined by the level of cd4, if equal or less than 200 cell count or WHO clinical 
staging). With the majority of cd4 results not documented (only 35% available from the 60% 
taken), there may be participants who have low cd4 count, but that is not known due to 
unavailability of results.  
On exploration of the relationship testing, Fischer’s exact yielded a significant relationship 
(Fischer’s exact= 20.80, d f=1, p=0.000) proving the significant difference between the women 




Figure 4.2 : showing HAART initiation against less than 200 cd4 cell count 
Despite cd4 cell count as the eligibility criteria to qualify for ART, WHO clinical staging is 
another form of determining whether a person qualify for ART (WHO: 2004). According to this 
criterion, cd4 cell count is not the only criterion to access for ART eligibility (Chopra: 2009). Of 






Table 4.5: Core PMTCT Activities   
Variable- core activity No. of charts with 
documented activity 
Percentage 
DT initiated at ANC  
98  
75% 
DT taken more than 4 weeks 43  33% 
Sd NVP taken in labour 91  70% 
AZT 3 hourly in labour  81 62% 
Cd4 count taken 
 
78 60% 
Cd4 count results documented 45  35% 
Cd4 count <200 cell count n=45 18 40% 
Cd4 count >200 cell count n=45 27 60% 
HAART initiated during pregnancy 
(of those eligible-) n=18 
10  56% 
WHO stage 3 or 4  
 
9 7% 
DT to the baby n 105 80% 
Feeding  counselling received 60  46% 
Opted for breast feeding 26  20% 
Opted for formula 63  48% 
AZT given to baby within 72 hrs 95 73% 
Easy access of PMTCT information 36  28% 
 
 
4.4 Documentation of key activities: n=15 
The total cardinal activities (15 activities) were chosen based on the Department of Health 
(2008) guidelines. These were considered to be the core activity that informs the program for 
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Prevention Of Mother to Child Transmission of HIV/AIDS. Having assessed each variable (see 
table 6), the proportion at which each was documented as done differs in all the activities. This 
section will then assess further on how many charts had activities documented. The activity 
documentation was divided into three groups that is 0 to 5 activities; 6 to10 activities and 7 to 15 
activities.  On exploring each file, there was no chart with all fifteen core activities documented. 
Table 4.6 indicates that majority of the charts n=107(82%) had between 6 to10 core activities 
documented, whilst n=12(9%) with 0 to 5 activities, and n=11(9%) had 11to 15 activities. This 
indicates that not all the required activities for PMTCT were performed as documented on the 
sampled charts. As the pregnancy progresses the opportunities are missed in each step of the 
PMTCT activity intervention.   
Table 4.6  :  Documentation of activities  
Documented activities in range 
N= 15 
Total no. of patient 




0—5 activities documented  12  9 % 
6—10 activities documented 107 82 % 
11—15 activities documented 11 9% 
 
On demonstrating the comparison of the documented activities, each chart was given a score 
based on the key activities of PMTCT. The maximum activities documented was 12.The median 
charts with documented activities was 28 (i.e. 22% of the sampled files) with at least 8 activities 
documented; the lowest charts had 4 of the core PMTCT activities documented n=3(2.3%). 
The top five commonly documented activities that were most frequently reported are presented 
in table 4.7. Majority of the charts had documented DT to baby initiated n=10(80%), DT 
initiation at ANC followed with n=98(75%) of charts with this core activity.  




Table: 4.7. Showing the top five commonly reported activities  
Core activity  Frequency  
1.Dual therapy (DT) given to baby 105(80%) 
2.Dual therapy initiation at ANC 98(75%) 
3. Single dose Nevirapine (sd NVP) taken by women 
in labour 
91(70%) 
4. AZT three hourly to woman in labour 81(62%) 
5. CD4 blood taken 78(60%) 
 
While these were documented, and were considered the core activities for PMTCT, no activity 
was reported more than 80% of the time. The Dual Therapy to baby n= 105(80%) is the crucial 
activity for PMTCT, but it was evidenced to work well when women had received the Dual 
Therapy initiated at antenatal clinic, which is documented less by 5% compared with the DT. 
 
 
Figure 4.3 : Top five activities documented  
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The least documented activities was WHO clinical staging with n= 9(7%) charts, followed by 
dual therapy taken more than four weeks, n=43(33).These are some of the crucial activities that 
should be perfomed in all the tested positive women while pregnant to minimise the risk of 
transmission. The bottom five activities documented, arranges from the least documented were 
as follows: 
1. World  Health Organisation clinical staging ( 7%) documented 
To  assess whether women is clinically eligible to start HAART even in the absence of cd4 
results. Each tested positive women is required to have gone through the assessment 
2. Dual therapy taken more than 4 weeks (33%) 
3. Feeding counselling received (46%) 
The feeding counselling choices should be decided on while pregnant, and has been identified as 
contributing to postnatal HIV/AIDS transmission (UNICEF: 2000).  
4. Cd4 result documented (35%) 
HAART for pregnant women rely on whether the cd4 count is equal or below 200 to qualify for 
treatment.  
5. HAART initiation to eligible women (56%)  




Figure 4.4   : Displaying the bottom list of activities documented  
  
4.5 Relationship amongst the key activities of PMTCT  
Table 4.1 demonstrate the upper and lower limit to which the activities can fall within even when 
applied elsewhere, with the percentage of charts with the number of the activities documented. 
The figure explains the confidence interval to guide the process of generalisation based on the 
sample. The charts with the most documented activities were n=28 (21.5 %) charts with at least 7 
of the 15 core activities documented resulting in the confidence interval of lower limit and upper 
limit (0.144—1.285) respectively, indicating that in the true population from which the sample 





Table 4.8 :  Percentage of documented activities and related confidence intervals  
No. of activities 
documented 
N=15 





CI for the  % of charts 
4 3 2.3% 0.002—0.049 
5 9 6.9%  0.025—0.113 
6 13 10% 0.003—0.217 
7 28 21.5% 0.144—1.285 
8 24 18.5% 0.118—0.252 
9 22 16.9% 0.105—0.233 
10 20 15.4% 0.092—0.216 
11 6 4.6% 0.009—0.082 
12 5 3.8% 0.005—0.071 
 
From the table 4.1, it shows that no chart had all the 15 activities documented. Instead the 
maximum was 12(n=15). The median charts with documented activities was n=24(18%) charts 
with at least n=8(53%) activities, and the most charts had n=7(22%) activities which was 
n=28(22%) charts. The lowest had n=4(27%)  PMTCT activities documented, a total of n=3(2%) 
charts.   
4.5.1 Cd4 results against cd4 done  
About n=78(60%) of women were done cd4 count, and only n=45 (35%) had documented 
results. A significance test result when Fischer’s exact test performed revealed (Fischer’s exact 
value= 37.69, d f =1, p=0.000). The results indicate that there is a significant difference between 
cd4 done and the availability of results. This imply that it is likely that not all participants done 
cd4 receive result  
4.5.2 Feeding choice  against employment status 
A total of n=60(46%) received feeding counselling to make informed choice, whilst n=70(54%) 
were recorded as not counselled on infant feeding. To determine the relationship, Pearson’s Chi 
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square revealed the non significance difference result (x 2 = value of 37.692, d f=1, p=0.29). The 
result suggest that there is no significant relationship between the choices that women make and 
their employment status, therefore the choices of infant feeding made is not influenced by the 
employment status in this study.  
4.5.3 Infant feeding counselling and the choice of infant feeding 
The choice of infant feeding was either formula feeding or breast feeding, there for was made 
binary variable. The majority of participants chose formula feeding n=63(48%) to breast feeding 
n=26(20%), when only n=60(46%) participants received infant feeding counselling to make 
informed choice. It implies that a total of n=70( 54% ) participants were not offered infant 
feeding counselling whilst n=41( 32% ) is not known what method of feeding was chosen .On 
exploring the relationship of the two variables, the Fischer’s exact test revealed (Fischer’s exact  
value= 0.123, df=1, p=0.000) , explaining the significant differences  in the choices made by 
women .With the new recommendations from WHO( 2010) it  made it clear on the importance of 
providing counselling for infant feeding to reduce the mixed feeding resulting in transmission of 
HIV/AIDS through post natal care.  
 




4.5.4 Breast feeding choice against age 
The women who are younger tend to not choose breast feeding method. This may be due to the 
influence of each other or stigma associated with breastfeeding options. What was observed is 
the high number of 19 year olds n=11(8%) of whom only n=3(2%) chose to breast feed. When 
comparing the breastfeeding option by women to age, the test statistic Fischer’s exact revealed 
(Fischer’s exact value= 46.85, d f=1, p= 0.000), which indicate the highly significant relationship 
between the choice of breast feeding and the age of women. That entails that the decision on 
breast feeding choice is influenced by age.   
 
4.6 Conclusion 
The results indicate that gaps still exist in provision and documentation of PMTCT activities, and 
that the demographic information contributes partly in the outcome of PMTCT. In age category, 
noted is the majority of the participants who were between the 20 to 26 years category (32%), 
with the category 39 years and above (4%) the minority. The majority of the participants were 
unemployed (77%) noticeable, the majority who were unemployed were single participants 
(85%). These results suggest the relationship between the employment status and the marital 
status (p=0.000). 
Dual therapy initiation at antenatal clinic is improving compared to previous studies (75%) 
although the 25% missed opportunity can be avoided. Most interesting result is that of 
Nevirapine to babies and mode of delivery. The results suggested that the administration of 
Nevirapine to babies is not affected by the mode of delivery of a pregnant women (p=0.114). 
This implies in this study that whether the deliver mode is normal vaginal delivery or by 
caesarean section, this will not change whether the baby will receive Nevirapine or not.  
It also shows that the testing for cd4 counts is still a gap, where 60% of the cd4 were done, and 
only 35% results were documented. This highlights  the poor documentation of intervention, for 
quality of care and for continuity of care in the next level of care. It cannot be over emphasised 
that unless it is documented, it is not done. The late testing for cd4 count may impact on the turn 
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around time for results, and initiation of eligible women onto lifelong Highly Active 
Antiretroviral therapy (HAART). Studies had proven that with low cd4 count (when the study 
was begun the cd4 was 200 mmol/l, the new guidelines allow 350 mmol/l  eligibility access for 
ART.  
 With only 46% infant feeding counselling done, the choice for infant feeding may be incorrect 
as no informed decision was made to support women, and to reduce the post natal transmission 
of HIV. With the new World Health Organisation Guidelines, the expectation is that women 
should make an informed choice, with an added benefit, Antiretroviral (Nevirapine ) to the baby 
to improve child health survival. Extensive counselling for women on making informed decision 
about what to feed their babies is therefore crucial. 
It is the requirement by World Health Organisation that all HIV positive women be clinically 
staged to determine eligibility for ART. With the new PMTCT guidelines that had been revised 
to enable women to access prophylactic ART with cd4 less than 350 (DOH:2009), as opposed to 
200 cd4 in the previous program (DOH:2008), it is needed that women are staged more so in 
cases where the cd4 count is not available enabling women to HAART. 
Minimize waiting times for ART to help women to assess treatment for their own health as well 
as for their babies. It is important that women who has low cd4 counts or WHO stage ¾ to access 
ART as they carry a risk of transmitting the virus to their unborn babies (weak immune system). 
This is also important to measure the effectiveness of the PMTCT program  
Evidence had shown that there is increased number of chances of transmission from a client with 
low cd4 count (McKellar, 2007)) as well as who has been assessed clinically as stage 3 or 4. This 
means that all measures need to be taken to get all necessary steps right so that by the time of 
delivery women received adequate care to assist in reduction of transmission. Most happen due 
to women who qualified for HAART, but were not initiated on time.  
The following chapter will then discuss major results, the recommendation as well as limitation 





 Discussion of major results, recommendations, limitation and conclusion 
5.1 Introduction 
The chapter will discuss the major results following the data analysis after the chart review study 
conducted that described the performance of PMTCT activities as documented. It will provide 
the design and methodology utilized in data collection,  then discuss the recommendation and 
limitation of the study  
5.2 Discussion of major results 
5.2.1 CD4 testing and cd4 results documentation 
The PMTCT service recommended by DOH (2008) includes investigation for cd4 when tested 
HIV positive, while also staging of clients, which then determines the Antiretroviral Therapy 
eligibility of clients. Stringer (2009) had shown that low cd4 increases the chances of 
transmission of HIV due to high viral load. There had been slight improvement in taking of cd4 
cell counts to HIV positive women (60%) as opposed to 57% in a study by Doherty (2009) yet it 
is expected according to the guidelines(DOH:2008) that cd4 should be done same day a client 
test positive and to all women found to be positive. With only 60% of participants recorded to 
have been taken cd4, indicates that 40 % (n130) were missed the opportunity to assess the level 
of cd4 to access treatment for their own health and for their children. a significant difference 
proved the association in the results and documentation (p=0.000). Horwood (2010) in the study 
to evaluate PMTCT, had shown that 78% of women were reported to have done cd4 count, but 
33% had the results recorded, which support this study that there is poor uptake of cd4  as well as 
unavailability of the cd4 results after it was taken. 
According to Tonwe-Gold (2007), early identification by cd4 results shown by availability of 
results and HAART initiation prior to delivery is essential for preventing the transmission from 
the mother to her child (MTCT). Considering the unavailability of cd4 results, it is possible that 
more women may have low cd4 (equal or less than 200) if only their results were available. 
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With the new Department of Health guidelines for PMTCT (2010), it is recommended that 
women should receive antiretroviral with at least 350 cd4 cell counts, which has improved from 
the previous 2008 (cd4 of 2oo cell count) DOH guidelines to allow women to access treatment 
early.  
The delay in results delay clients in accessing lifelong therapy,  HAART since World Health 
Organisation staging is poorly documented as well  with only 9 /130(7%)  were clinically 
assessed, yet the World Health Organisation had recommended that all HIV positive tested 
clients should be clinically staged to determine HAART eligibility, and not only relying on cd4 
results. A low cd4 count was associated with high viral load thereby increasing the chances for 
mother to child transmission.  
5.2.2 HAART initiation whilst pregnant 
The study revealed the gap in HAART initiation to eligible pregnant women, and gap in cd4 
results availability. Amongst the inclusion criteria, one of them was that of attendance to ANC 
four times and more. This shows that woman presented themselves at least four times that they 
had the opportunity to had undergone PMTCT interventions.  
A total of 18/130(18%) participants had low cd4 (equal and less than 200 cd4. of the n=18 
participants.  About 10 (55%) were initiated onto HAART.  With Kwa Zulu Natal being one of 
the Provinces with highest HIV antenatal sero-prevalence at 38.7 (NDOH: 2009), the PMTCT 
program will bear results once all the processes of care and activities are provided to all women 
found to be HIV infected to be able to meet the NSP target (DOH: 2007) of reducing MTCT to 
less than 5% by 2011) as well as documentation of processes on patients records 
The study highlights the fact that there are still gaps in the documentation of core PMTCT 
activities that if not performed may have negative outcome to a child or women. This is made 
worst by poor recording of the simple PMTCT activities yet complicated by occurring at 




5.2.3 Antiretroviral prophylaxis initiation ( Dual prophylaxis= Nevirapine and Zidovudine-
AZT) 
It is recommended that pregnant women who are tested HIV positive but not yet eligible for life 
long therapy of ART, should receive the ART prophylactic drugs (Zidovudine and Nevirapine 
called Dual therapy prophylaxis) for prevention of transmission of HIV from mother to child at 
the time of study the criterion was that the prophylaxis should be started from 28 weeks of 
pregnancy (DOH:2008), yet the new PMTCT guidelines ( DOH :2010) had made 
recommendation fro the prophylaxis to be started from 14 weeks of pregnancy. The prophylaxis 
had proved that if implemented well at 28 weeks, it can reduce transmission to less than 5% 
(Chopra : 2009).  
A total of n=98 (75%) of women had received nevirapine at antenatal clinic, which is lower than 
Horwood (2010) study which had found that 91% received nevirapine at antenatal clinic, whilst 
n=91(70%) taken nevirapine in labour. This highlight the quality gaps in the provision of 
services. With 98 participants receiving dual therapy, the remaining n=32(35%)  may seems like 
the small number, but this counts to the number of exposed children that may be infected due to 
missed opportunity, whilst their mothers had attended antenatal care for more than four times ( 
eligibility criteria for this study). The opportunity was there, but women are missed. With 
increasing child mortality in the developing countries like South Africa, interventions that have 
proven to work in the same resource limited settings like Khayelitsha from Western Cape,  
succeeded  in reducing vertical transmission in 2007, to less than 3.5% (Doherty :2007). This 
suggest that PMTCT can reach all mothers who need service and count down to United Nations 
Millennium development  goals ( by 2015 reducing MTCT to less than 5%) and National 
Strategic plan (SADOH:2007) to reduce transmission of HIV from mother to child to less than 
5% by 201.  
5.2.4 Infant feeding Practises 
Besides vertical transmission of HIV, infant feeding is one of the methods that may contributes 
to post natal transmission of HIV. Although the focus is not much on this method of 
transmission, but it has been noted that breast feeding can contribute to transmission. A total of 
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n=60 (46%) of participants that received infant feeding counselling according to records. Of the 
46% that received infant feeding counselling, n=26(20%) chose to breast feed whilst n=34 (26%) 
had chosen formula feeding. With the new World Health Organisation recommendation for 
infant feeding (WHO: 2009), includes the use of antiretroviral interventions to babies 
(Nevirapine syrup) while babies are breast fed, in reducing the transmission at post natal period. 
With the new recommendation , it is strongly emphasised the importance of  counselling to make 
informed choice to improve HIV free survival oh HIV exposed infants , thus improving the HIV 
infected women. With the DOH guidelines (2009), the formula was provided free of charge to 
women who are found to be positive and chose to formula feed. While in the new upcoming 
recommendation by World Health Organisation (2010) guidelines which have not yet finalised 
by the South African Department of Health , it is hoped that women should consider breast 
feeding as the first choice (Coutsoudis : 2009), in the low resourced countries like South Africa.   
The rationale for counselling has always been to ensure that the correct method is chosen, 
information is provided for women to make a choice to avoid the post natal transmission of HIV.  
5.2.5 Accessing PMTCT information 
Access to information about activities of PMTCT was challenging to extract with only 
n=36(28% ) documents, had the PMTCT activities centrally located for easy access , to ease 
intervention, the rest n=94(72%) was located all over the chart, that was time consuming for 
continuum of care. This may result in health worker having to miss this crucial information in 
the health care system that always is short staffed in the maternity section.  The low initiation 
rate also poses a concern for pregnant women’s health. All charts for women with low cd4 had 
documented that the women was referred for ART, yet no initiation was done as per documents. 
This can be attributed to the  disintegrated services, This was noted through the recording stated 
that clients to be referred for initiation to the next site, by not providing the package of services 
in one facility as most clinics do not offer ART on site. Long waiting times for counselling on 
adherence to HAART drug regimen was noted in documents.  
The low uptake of HAART in pregnancy is a concern. Considering that most clients couldn’t 
have the results, it may have been that more qualify for HAART, has it be that their results are 
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unknown. The studies done had revealed that there is increased transmission with low cd4 count. 
Provincial DOH (2008) has made a memorandum that since women that are pregnant are a 
priority, they should be initiated within two weeks of discovering their status. In other developed 
countries like Europe , pregnant women found to be HIV positive are put on Triple therapy ARV 
to reduce transmission, to which they have succeeded in reducing it to less than 2% 
(UNAIDS:2008) .  
The poor availability of cd4 results , 60% taken, with only 35% results available in documents is 
a concern for maternal and child survival, which implies that pregnant women will not receive 
the expected quality of care that should be rendered to them, thereby missing the opportunity for 
children born to  these women. The unavailable results may be low cd4 cell count that requires 
that women undergo advanced treatment, as opposed to prophylaxis Dual therapy.  
Documentation translates to practise, if it is not documented, it is not done. With the complexity 
of the PMTCT program occurring in different settings, the documents serve as the 
communication tool to all the levels of care, with the interventions documented to guide the next 
intervention. The cd4 cell count is the key eligibility criteria as well as WHO clinical staging that 
determines whether lifelong antiretroviral should be prescribed for women. With only 9/130 
(7%) of charts with staging recorded, whilst cd4 uptake is poor, women are lost which may 
increase the chances to transmission.  
The gaps identified will be evident more in the follow up of clients for testing of babies born to 
HIV positive women. The importance of clear documentation of activities couldn’t be over 
emphasise by the fact that the services are rendered at different levels of care (Ante natal care, 
labour ward, as well as post natal care) 
If South Africa is to succeed in meeting the MDG goals (Millennium Development Goals (goal 
5- which stresses the prevention of HIV), and that of National Strategic Plan (NSP: 2007-2011-
2013,  that of reducing MTCT from 21% to less than 5% by 2015 , the country has to ensure that 
all the necessary interventions for the priority program (PMTCT) should be clearly documented 




5.3 CONCLUSION AND RECOMMENDATION 
Recommendations 
Despite the burden posed by HIV pandemic, documentation of vital steps for access to 
intervention strategy (PMTCT AND HAART) remains poor. This is despite the established 
PMTCT ART programs, the majority of women are missed which may result in poor outcome 
such as child mortality, that represents failure of the program. The chapter will provide 
recommendations that will cover the following: the nursing education, recommendation for 
clinical practise, for research as well as the recommendation for nursing management.  
5.3.1 Recommendat ion for Nursing Education 
South Africa has good health policies and guidelines; however the country must ensure that these 
policies and guidelines are translated into practise. Support should be offered to the health 
workers especially nurses, to ensure that guidelines are adhered to, and that the nursing 
curriculum emphasising the importance of documentation more especially by the nurses, and 
ensures that necessary measures are taken to ensure accountability of the health workers in 
documenting their practise. A need to ensure that monitoring and evaluation tools are available 
to monitor the progress of the program 
5.3.2 Recommendat ion for clinical practise 
Quality of care should be rendered to every client to ensure that health promotion, prevention of 
diseases that contributes to child transmission of HIV. Proper documentation by health workers 
to facilitate ongoing continuum of care,  and assisting with the evaluation of the program which 
remains the challenge. This involves accountability on the part of health workers and providing 
quality of care.  A need for accountability, must also realize that documenting the practice has 
and will always be the only way of ensuring that the right intervention is received, as if not 






5.3.3 Recommendat ion for future research 
A large  study that will follow up to see whether DT resulted in prevention of mother to child 
transmission. The follow up for children to assess whether mother to child transmission was 
reduced, a prospective study that will follow up more so, the HIV exposed children (children 
born to HIV positive women) to see the transmissions averted. Chart reviews research in nursing 
is poorly done.  More chart review studies should be encouraged, to identify gaps for prompt 
action.  
5.3.4 Recommendat ion for nursing management 
The study had revealed gaps in the provision of Prevention of Mother to Child transmission 
program. Documents revealing missed opportunities for women who did not receive care as 
outlined in the PMTCT guideline (DOH: 2008). The onus is on nurse managers in the institutions 
to ensure that the guidelines are adhered to, and emphasize the importance of documentation. 
Through routine charts audits, the gaps can be identified swift, and actions taken to correct gaps. 
The managers should ensure that the health workforce are skilled and know the guidelines and 
protocols to guide the practise, and necessary measures in terms of accountability, to be taken for 
not adhering to the required practise that may lead to poor quality of care rendered to patients.  
5.4 Study Limitations 
Limitation to the study include that the chart review didn’t track post natal recording of babies’ 
charts for documentation of  HIV exposure to make a follow up at the clinic, whether postnatal 
care was recorded in Road To Health Card. This will help to communicate the need for an HIV 
test for a child. 
Although Chart reviews reveal lot of gaps, it may have excluded some information which have 
been missed, but also this is the strength of the study to reinforce documentation of interventions. 
It is ethically needed to document the intervention to clients. 
 The sample size was not powered but was calculated based on the previous studies done, which 
may not be adequate for this study.  Another study needed which will explore the reasons why 
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cd4 results are always missing, a need to investigate further. A qualitative study, that will 
prospectively explore and investigate the reasons for poor documentation is needed.  
5.4.1 Selection bias 
A choice of public hospital only may have led to selection bias as the results may not be 
generalised to the private setting. Mothers who do not attend antenatal care, and deliver at home 
were excluded. Having a researcher extracting data may result in selection bias. 
5.4.2 Information bias 
The study relies on data collected for routine monitoring, which may result in errors in written 
records.  
5.5 Strength of the study 
The use of already collected data, routine data, by using patients medical records strengthen the 
study, as was collected independent of the study. 
Less   exposed to internal validity since the study focused  on clinical charts review. 
Less information bias as it relied on primary clinical records. 
5.6 Summary and Conclusion  
The study provided with new knowledge and insight whether the Prevention of Mother to Child 
transmission of HIV program activities are documented as performed in different settings shown 
by patient records.    
It had made it clear that all the package of activities is crucial and interdependent. All of the 
activities should be perfomed for effective PMTCT program that will help improve the child and 
maternal survival of participants. It has brought to light that although the activities are perfomed, 
but not to an acceptable level for most of the Sub Saharan countries like South Africa, which has 
the highest HIV disease burden. Also that the target for Millennium Development goals can be 
achieved if all the small multi step, multi-setting activities which may be considered small, can 




Although the study had limitations, but this study will help to bring in the new knowledge which 
will assist in the evaluation of the program for effectiveness thus highlight the need for 
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Appendix One: Data Extraction Tool  
 
CHART REVIEW STANDARD SHEET : DATA EXTRACTION TOOL 
A Retrospective Clinical Chart Review study on the core PMTCT activities at a Regional hospital in  Durban,Kwa Zulu Natal 
This data must be extracted from all charts selected for the study.  




3. Record Number------------------ 
DEMOGRAPHIC DATA 
1. Age                                      :    
2. Marital status                        :  i. single      ii. Married      iii. Divorced    iv. widowed 
3. Employment status                : i. Employed      ii. Unemployed 
4. Testing for cd4                        : i. At first visit   ii. Tested later 
5. Type of delivery                     :  i. Normal vaginal delivery        ii. Caesarean section 
6. Parity                                     :   i. First pregnancy                       ii. More than one 
7. Baby's birth weight                 : i. 1.5 kg and above                     ii. Below 1.5 kg 
PART TWO 
     Key Activities of PMTCT   
      Is the HIV status of the patient clearly documented                        Yes:             No 
      Dual therapy ( Antiretroviral prophylaxis) 
      To the pregnant mother 
      Was Dual Therapy initiated at Antenatal clinic 
      Was DT taken more than 4 weeks by pregnant  woman 
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      Was single dose NVP taken in labour 
      Was AZT taken 3hrly during labour 
       CD4 Testing 
       Was CD4 count taken 
        Are the results documented                                
       If results are documented, indicate by means of a circle: 
a. =/<200 mmol/l                           b.    >200 mmol/l 
       Is there WHO clinical staging recorded 
Dual Therapy to the baby 
  
a. Was there  records of sd NVP given to the baby after delivery within 72 hours 
Antiretroviral Treatment : HAART initiation 
b. Was HAART initiation documented if low cd4 count 
c. If not initiated, was referral to initiation site documented 
  
Discharge plan 
a. Is there a record of the DT to be taken by the child after  
b. Is there a summary of the follow up entered 
c. Is there any records of infant feeding counseling charted in file 
d. Method of feeding chosen 
Totals : 
  
PART THREE: Accessing information 
Did the chart has clearly documentation of PMTCT interventions      Y/N 
  






Appendix Two : Ethical Clearance for the study from the Ethics Committee 
 
03 December 2010 




BICrMdk.J1 R.search Ethk5 Admlnlsb'ation 
Westville Campus, Govan MbeklBuilding 
PrivAte Bag X 54001 
Durban 
<000 
KwaZulu·Natal, SOUTH AFRICA 
TeL: 27 312604769· Fa" 2731 2604609 
Email: BREC@ylgn ac za 
Website: http:// research. ukzn . oc.za IResearchEthics/BiomedicatResearchEthics.~ 
School of Nursing Howard College Building 
University of KwaZulu· Natal 
PROTOCOL:A retrospective clinical chart review study on the core PMTCT 
activities at a Regional hospital In Durban, KwaZulu·Natal. REF: BE240109. 
Dea r Ms Ngidi 
EXPEDITED APPLICATION 
A sub'committee of the Biomedical Research Ethics Committee has considered and 
noted your application dated 16 October 2009. 
The study was provisionally approved pending appropriate responses to queries 
raised. Your responses dated 29 November 2010 to queries raised on 26 January 
2010: have been noted by. a sub·committee of the Biomedical Research Ethics 
Colli'mlttee. The conditions have now been met and the study is given full ethics 
approvai' and may begin as from 03 December 2010. 
This approval is valid for one year from 03 December 2010. To ensure 
uninterrupted approval of this study beyond the approval expiry date, an 
application for recertification must be submitted to BREC on the appropriate BREC 
form 2·3 months before the expiry date. 
Any amendments to this study, unless urgently required to ensure safety of 
participants, must be approved by BREC prior to implementation. 
Your acceptance of this approval denotes your compliance with South African 
National Research Ethics Guidelines (2004), South African National Good Clinical 
Practice Guidelines (2006) (if applicable) and with UKZN BREC ethics requirements 
as contained in the UKZN BREC Terms of Reference and Standard Operattng 




BREC is registered with the South African NationaL Health Research Ethics CoundL 
(REC-290408-009). BREC has US Office for Human Research Protections (OHRP) 
Federal-wide Assurance (FWA 678). 
The sub·committee's decision will be RATIFIED at a full sitting of t e Biomedical 
Research Ethics Committee meeting to be held on 08 February 2011. 
We wish you well with this study. We wouLd appreciate receiving copies of aLL 
pubLications arising out of this study. 
Yours sincerely 
Professor D.R Wassenaar 





Appendix Three:  Letter requesting permission from King Edward V111 
Hospital  
3 B Bass Place 
       Newlands East 
       4037 
       19 February 2010 
The Hospital Manager 
Kind Edward V111 Hospital 





APPLICATION FOR PERMISSION TO CONDUCT A RESEARCH STUDY 
Research Topic : A retrospective clinical chart review study on the core PMTCT activities 
at a Regional hospital in Durban, Kwa Zulu Natal.  
I wish to request permission to conduct a research project at King Edward V111 hospital.  
I am a 34 year old female who is currently studying Masters in Nursing Research –Coursework. 
Part of the requirement for my studies requires that I conduct a Research project in the area of 
my interest. I am currently not involved in any research at King Edward hospital.  
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The project is about review of pregnant women’s charts, looking at documentation from when 
they attended clinic to when they deliver at hospital. It looks at the provision of PMTCT 
activities whether they were conducted, through records. The study is not intended to disturb the 
functions of the hospital since it will be the reviews of charts which will be conducted by the 
researcher herself and not the personnel. The reviews will be done retrospectively, only the 
charts documents will be used when clients have been discharged.  
I declare that no funding has been sort to conduct this research.  
I hope my request to be successful 
Thank you  
Researcher  : Miss Hlolisile Ngidi 
Work: 031 260 4648 
Cell: 076 317 9187 
Research Supervisor: Mrs J. Naidoo 














Appendix  Four : Letter of permission to conduct the study from King Edward V111 
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